Bcl-3	B-protein
expression	O
and	O
nuclear	O
translocation	O
are	O
induced	O
by	O
granulocyte-macrophage	B-protein
colony-stimulating	I-protein
factor	I-protein
and	O
erythropoietin	B-protein
in	O
proliferating	B-cell_type
human	I-cell_type
erythroid	I-cell_type
precursors	I-cell_type
.	O

Bcl-3	B-protein
is	O
a	O
proto-oncogene	B-DNA
involved	O
in	O
the	O
chromosomal	O
translocation	O
t	B-DNA
(	I-DNA
14	I-DNA
;	I-DNA
19	I-DNA
)	I-DNA
found	O
in	O
some	O
patients	O
with	O
chronic	O
lymphocytic	O
leukemia	O
.	O

It	O
shares	O
structural	O
similarities	O
with	O
and	O
is	O
a	O
member	O
of	O
the	O
IkappaB	B-protein
family	I-protein
of	O
proteins	O
.	O

In	O
this	O
report	O
,	O
involvement	O
of	O
Bcl-3	B-protein
in	O
hematopoietic	O
growth	O
factor-stimulated	O
erythroid	O
proliferation	O
and	O
differentiation	O
was	O
examined	O
.	O

In	O
TF-1	B-cell_line
cells	I-cell_line
,	O
an	O
erythroleukemia	B-cell_line
cell	I-cell_line
line	I-cell_line
,	O
granulocyte-macrophage	B-protein
colony-stimulating	I-protein
factor	I-protein
(	O
GM-CSF	B-protein
)	O
and	O
erythropoietin	B-protein
(	O
Epo	B-protein
)	O
greatly	O
enhanced	O
Bcl-3	B-protein
expression	O
at	O
both	O
the	O
protein	O
and	O
mRNA	O
levels	O
in	O
association	O
with	O
stimulation	O
of	O
proliferation	O
.	O

Bcl-3	B-protein
protein	O
was	O
also	O
highly	O
expressed	O
in	O
early	B-cell_type
burst-forming	I-cell_type
unit-erythroid	I-cell_type
(	I-cell_type
BFU-E	I-cell_type
)	I-cell_type
-derived	I-cell_type
erythroid	I-cell_type
precursors	I-cell_type
(	O
day	O
7	O
)	O
and	O
decreased	O
during	O
maturation	O
(	O
days	O
10	O
and	O
14	O
)	O
,	O
suggesting	O
that	O
Bcl-3	B-protein
is	O
involved	O
in	O
normal	O
erythroid	O
proliferation	O
.	O

In	O
these	O
hematopoietic	B-cell_type
cells	I-cell_type
,	O
Bcl-3	B-protein
was	O
hyperphosphorylated	O
.	O

GM-CSF	B-protein
and	O
Epo	B-protein
modulated	O
the	O
subcellular	O
localization	O
of	O
Bcl-3	B-protein
.	O

Upon	O
stimulation	O
of	O
TF-1	B-cell_line
cells	I-cell_line
with	O
GM-CSF	B-protein
or	O
Epo	B-protein
,	O
the	O
nuclear	O
translocation	O
of	O
Bcl-3	B-protein
was	O
dramatically	O
enhanced	O
.	O

Overexpression	O
of	O
Bcl-3	B-protein
in	O
TF-1	B-cell_line
cells	I-cell_line
by	O
transient	O
transfection	O
along	O
with	O
the	O
NF-kappaB	B-protein
factors	I-protein
p50	I-protein
or	I-protein
p52	I-protein
resulted	O
in	O
significant	O
induction	O
of	O
an	O
human	B-DNA
immunodeficiency	I-DNA
virus-type	I-DNA
1	I-DNA
(	I-DNA
HIV-1	I-DNA
)	I-DNA
kappaB-TATA-luceriferase	I-DNA
reporter	I-DNA
plasmid	I-DNA
,	O
demonstrating	O
that	O
Bcl-3	B-protein
has	O
a	O
positive	O
role	O
in	O
transactivation	O
of	O
kappaB-containing	B-DNA
genes	I-DNA
in	O
erythroid	B-cell_type
cells	I-cell_type
.	O

Stimulation	O
with	O
GM-CSF	B-protein
enhanced	O
c-myb	B-RNA
mRNA	I-RNA
expression	O
in	O
these	O
cells	O
.	O

Bcl-3	B-protein
in	O
nuclear	O
extracts	O
of	O
TF-1	B-cell_line
cells	I-cell_line
bound	O
to	O
a	O
kappaB	B-DNA
enhancer	I-DNA
in	O
the	O
c-myb	B-DNA
promoter	I-DNA
together	O
with	O
NF-kappaB2/p52	B-protein
and	O
this	O
binding	O
activity	O
was	O
enhanced	O
by	O
GM-CSF	B-protein
stimulation	O
.	O

Furthermore	O
,	O
cotransfection	O
of	O
Bcl-3	B-protein
with	O
p52	B-protein
or	O
p50	B-protein
in	O
TF-1	B-cell_line
cells	I-cell_line
resulted	O
in	O
significant	O
activation	O
of	O
a	O
c-myb	B-DNA
kappaB-TATA-luceriferase	I-DNA
reporter	I-DNA
plasmid	I-DNA
.	O

These	O
findings	O
suggest	O
that	O
Bcl-3	B-protein
may	O
participate	O
in	O
the	O
transcriptional	O
regulation	O
of	O
certain	O
kappaB-containing	B-DNA
genes	I-DNA
involved	O
in	O
hematopoiesis	O
,	O
including	O
c-myb	B-DNA
.	O

Copyright	O
1998	O
by	O
The	O
American	O
Society	O
of	O
Hematology	O
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Bcl-3	NULL
Expression	NULL
and	NULL
Nuclear	NULL
Translocation	NULL
Are	NULL
Induced	NULL
by	NULL
Granulocyte-Macrophage	NULL
Colony-Stimulating	NULL
Factor	NULL
and	NULL
Erythropoietin	NULL
in	NULL
Proliferating	NULL
Human	NULL
Erythroid	NULL
Precursors	NULL
By	NULL
Min-Ying	NULL
Zhang	NULL
,	NULL
Edward	NULL
W.	NULL
Harhaj	NULL
,	NULL
Laurie	NULL
Bell	NULL
,	NULL
Shao-Cong	NULL
Sun	NULL
,	NULL
and	NULL
Barbara	NULL
A.	NULL
Miller	NULL
Bel-3	NULL
is	NULL
a	NULL
proto-oncogene	NULL
involved	NULL
in	NULL
the	NULL
chromosomal	NULL
translocation	NULL
t	NULL
(	NULL
14	NULL
;	NULL
19	NULL
)	NULL
found	NULL
in	NULL
some	NULL
patients	NULL
with	NULL
chronic	NULL
lymphocytic	NULL
leukemia	NULL
.	NULL

It	NULL
shares	NULL
structural	NULL
similarities	NULL
with	NULL
and	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
IB	NULL
family	NULL
of	NULL
proteins	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
involvement	NULL
of	NULL
Be/-3	NULL
in	NULL
hematopoietic	NULL
growth	NULL
factor-stimulated	NULL
erythroid	NULL
proliferation	NULL
and	NULL
differentiation	NULL
was	NULL
examined	NULL
.	NULL

In	NULL
TF-1	NULL
cells	NULL
,	NULL
an	NULL
erythroleukemia	NULL
cell	NULL
line	NULL
,	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
and	NULL
erythropoietin	NULL
(	NULL
Epo	NULL
)	NULL
greatly	NULL
enhanced	NULL
Be/-3	NULL
expression	NULL
at	NULL
both	NULL
the	NULL
protein	NULL
and	NULL
mRNA	NULL
levels	NULL
in	NULL
association	NULL
with	NULL
stimulation	NULL
of	NULL
proliferation	NULL
.	NULL

Bcl-3	NULL
protein	NULL
was	NULL
also	NULL
highly	NULL
expressed	NULL
in	NULL
early	NULL
burst-forming	NULL
unit-erythroid	NULL
(	NULL
BFU-E	NULL
)	NULL
-derived	NULL
erythroid	NULL
precursors	NULL
(	NULL
day	NULL
7	NULL
)	NULL
and	NULL
decreased	NULL
during	NULL
maturation	NULL
(	NULL
days	NULL
10	NULL
and	NULL
14	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
Bcl-3	NULL
is	NULL
involved	NULL
in	NULL
normal	NULL
erythroid	NULL
proliferation	NULL
.	NULL

In	NULL
these	NULL
hematopoietic	NULL
cells	NULL
,	NULL
Bel-3	NULL
was	NULL
hyperphosphorylated	NULL
.	NULL

GM-CSF	NULL
and	NULL
Epo	NULL
modulated	NULL
the	NULL
subcellular	NULL
localization	NULL
of	NULL
Bcel-3	NULL
.	NULL

Upon	NULL
stimulation	NULL
of	NULL
TF-1	NULL
cells	NULL
with	NULL
GM-CSF	NULL
or	NULL
Epo	NULL
,	NULL
the	NULL
nuclear	NULL
translo-	NULL
Bel-3	NULL
WAS	NULL
FIRST	NULL
IDENTIFIED	NULL
from	NULL
a	NULL
chronic	NULL
lympho-	NULL
cytic	NULL
leukemia	NULL
(	NULL
CLL	NULL
)	NULL
patient	NULL
with	NULL
the	NULL
chromosomal	NULL
translocation	NULL
t	NULL
(	NULL
14	NULL
;	NULL
19	NULL
)	NULL
(	NULL
q32	NULL
;	NULL
q13.1	NULL
)	NULL
.	NULL
'	NULL

This	NULL
breakpoint	NULL
junction	NULL
does	NULL
not	NULL
affect	NULL
the	NULL
structural	NULL
integrity	NULL
of	NULL
Bei-3	NULL
,	NULL
but	NULL
results	NULL
in	NULL
the	NULL
overexpression	NULL
of	NULL
Bcl-3	NULL
mRNA	NULL
in	NULL
leukemic	NULL
cells	NULL
!	NULL

Bcl-3	NULL
overexpression	NULL
is	NULL
proposed	NULL
to	NULL
contribute	NULL
to	NULL
the	NULL
development	NULL
of	NULL
CLL	NULL
through	NULL
dysregulation	NULL
of	NULL
a	NULL
gene	NULL
(	NULL
s	NULL
)	NULL
normally	NULL
regulated	NULL
by	NULL
NE-	NULL
«	NULL
B	NULL
transcription	NULL
factors	NULL
and	NULL
important	NULL
in	NULL
cell	NULL
proliferation	NULL
and	NULL
differentiation	NULL
.	NULL
``	NULL

The	NULL
Bel-3	NULL
protein	NULL
has	NULL
a	NULL
distinct	NULL
pattern	NULL
of	NULL
ankyrin-related	NULL
repeats	NULL
and	NULL
is	NULL
structurally	NULL
similar	NULL
to	NULL
other	NULL
members	NULL
of	NULL
the	NULL
IB	NULL
family	NULL
of	NULL
proteins	NULL
,	NULL
including	NULL
IxBa	NULL
,	NULL
IBB	NULL
,	NULL
and	NULL
IxBy.3	NULL
>	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

designates	NULL
a	NULL
widely	NULL
distributed	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
that	NULL
modulate	NULL
the	NULL
expression	NULL
of	NULL
genes	NULL
involved	NULL
in	NULL
immune	NULL
and	NULL
acute-phase	NULL
responses	NULL
as	NULL
well	NULL
as	NULL
the	NULL
response	NULL
to	NULL
signals	NULL
for	NULL
rapid	NULL
gene	NULL
expression	NULL
.	NULL
``	NULL

The	NULL
DNA-binding	NULL
forms	NULL
of	NULL
NE-	NULL
«	NULL
B	NULL
transcription	NULL
factors	NULL
are	NULL
heterodimers	NULL
or	NULL
homodimers	NULL
composed	NULL
of	NULL
different	NULL
combinations	NULL
of	NULL
5	NULL
structurally	NULL
related	NULL
DNA-binding	NULL
proteins	NULL
,	NULL
p50	NULL
,	NULL
p52	NULL
,	NULL
RelA	NULL
(	NULL
p65	NULL
)	NULL
,	NULL
RelB	NULL
,	NULL
and	NULL
c-Rel	NULL
.	NULL

These	NULL
proteins	NULL
share	NULL
a	NULL
highly	NULL
conserved	NULL
amino-terminal	NULL
sequence	NULL
called	NULL
the	NULL
Rel	NULL
homology	NULL
region	NULL
(	NULL
RHR	NULL
)	NULL
.	NULL
``	NULL

Specific	NULL
heterodimers	NULL
or	NULL
homodimers	NULL
of	NULL
these	NULL
proteins	NULL
bind	NULL
to	NULL
target	NULL
enhancer	NULL
elements	NULL
(	NULL
«	NULL
B	NULL
)	NULL
present	NULL
in	NULL
the	NULL
promoters	NULL
of	NULL
regulated	NULL
genes	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
these	NULL
proteins	NULL
is	NULL
regulated	NULL
through	NULL
cytoplasmic	NULL
retention	NULL
by	NULL
physical	NULL
interaction	NULL
with	NULL
cytoplasmic	NULL
inhibitors	NULL
termed	NULL
IxB	NULL
.	NULL
``	NULL

''	NULL
IxB	NULL
proteins	NULL
interact	NULL
with	NULL
the	NULL
RHR	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
through	NULL
their	NULL
ankyrin	NULL
repeats.8	NULL
Stimulation	NULL
of	NULL
cells	NULL
with	NULL
NF-KB	NULL
inducers	NULL
leads	NULL
to	NULL
rapid	NULL
phosphorylation	NULL
and	NULL
degradation	NULL
of	NULL
IKxBs	NULL
,	NULL
allowing	NULL
NF-KB	NULL
to	NULL
translocate	NULL
to	NULL
the	NULL
nucleus	NULL
to	NULL
activate	NULL
targets	NULL
.	NULL
``	NULL

Based	NULL
on	NULL
protein	NULL
structural	NULL
similarities	NULL
and	NULL
interaction	NULL
with	NULL
proteins	NULL
,	NULL
Bel-3	NULL
is	NULL
considered	NULL
to	NULL
be	NULL
a	NULL
member	NULL
of	NULL
the	NULL
IxB	NULL
family	NULL
.	NULL

However	NULL
,	NULL
despite	NULL
structural	NULL
homology	NULL
,	NULL
Bel-3	NULL
and	NULL
IxBs	NULL
appear	NULL
to	NULL
have	NULL
different	NULL
roles	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

l	NULL
proteins	NULL
.	NULL

Whereas	NULL
IxBa	NULL
is	NULL
primarily	NULL
cytoplasmic	NULL
,	NULL
transiently	NULL
transfected	NULL
Bel-3	NULL
protein	NULL
is	NULL
predominantly	NULL
located	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

>	NULL
>	NULL
``	NULL
IxBa	NULL
inhibits	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-kB/	NULL
Blood	NULL
,	NULL
Vol	NULL
92	NULL
,	NULL
No	NULL
4	NULL
(	NULL
August	NULL
15	NULL
)	NULL
,	NULL
1998	NULL
:	NULL
pp	NULL
1225-1234	NULL
cation	NULL
of	NULL
Bel-3	NULL
was	NULL
dramatically	NULL
enhanced	NULL
.	NULL

Overexpression	NULL
of	NULL
Bcel-3	NULL
in	NULL
TF-1	NULL
cells	NULL
by	NULL
transient	NULL
transfection	NULL
along	NULL
with	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
factors	NULL
p50	NULL
or	NULL
p52	NULL
resulted	NULL
in	NULL
significant	NULL
induction	NULL
of	NULL
an	NULL
human	NULL
immunodeficiency	NULL
virus-type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
«	NULL
B-TATA-luceriferase	NULL
reporter	NULL
plasmid	NULL
,	NULL
demonstrating	NULL
that	NULL
Bcl-3	NULL
has	NULL
a	NULL
positive	NULL
role	NULL
in	NULL
transactivation	NULL
of	NULL
«	NULL
B-containing	NULL
genes	NULL
in	NULL
erythroid	NULL
cells	NULL
.	NULL

Stimulation	NULL
with	NULL
GM-CSF	NULL
enhanced	NULL
emyb	NULL
mRNA	NULL
expression	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Bcel-3	NULL
in	NULL
nuclear	NULL
extracts	NULL
of	NULL
TF-1	NULL
cells	NULL
bound	NULL
to	NULL
a	NULL
xB	NULL
enhancer	NULL
in	NULL
the	NULL
c-myb	NULL
promoter	NULL
together	NULL
with	NULL
NF-	NULL
«	NULL
B2/p52	NULL
and	NULL
this	NULL
binding	NULL
activity	NULL
was	NULL
enhanced	NULL
by	NULL
GM-CSF	NULL
stimulation	NULL
.	NULL

Furthermore	NULL
,	NULL
cotransfection	NULL
of	NULL
Bel-3	NULL
with	NULL
p52	NULL
or	NULL
p50	NULL
in	NULL
TF-1	NULL
cells	NULL
resulted	NULL
in	NULL
significant	NULL
activation	NULL
of	NULL
a	NULL
e-myb	NULL
«	NULL
B-TATA-luceriferase	NULL
reporter	NULL
plasmid	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
that	NULL
Bcl-3	NULL
may	NULL
participate	NULL
in	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
certain	NULL
«	NULL
B-containing	NULL
genes	NULL
involved	NULL
in	NULL
hematopoiesis	NULL
,	NULL
including	NULL
e-myb	NULL
.	NULL

©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

Rel	NULL
,	NULL
whereas	NULL
Bel-3	NULL
does	NULL
not	NULL
.	NULL
``	NULL

''	NULL
Bel-3	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
form	NULL
complexes	NULL
with	NULL
p50'°	NULL
or	NULL
p52°	NULL
%	NULL
``	NULL
!	NULL

homodimers	NULL
that	NULL
serve	NULL
as	NULL
transcriptional	NULL
coactivators	NULL
of	NULL
<	NULL
B-specific	NULL
gene	NULL
expression	NULL
.	NULL

Under	NULL
certain	NULL
conditions	NULL
,	NULL
Bel-3	NULL
may	NULL
also	NULL
function	NULL
to	NULL
antagonize	NULL
the	NULL
DNA	NULL
binding	NULL
of	NULL
nuclear	NULL
p50	NULL
homodimers	NULL
,	NULL
which	NULL
can	NULL
be	NULL
xB-specific	NULL
repressors	NULL
of	NULL
active	NULL
forms	NULL
of	NULL
NF-	NULL
«	NULL
kB/Rel1	NULL
.	NULL

>	NULL
>	NULL
``	NULL
Thus	NULL
,	NULL
these	NULL
transient	NULL
transfection	NULL
studies	NULL
suggest	NULL
that	NULL
Bel-3	NULL
plays	NULL
a	NULL
positive	NULL
regulatory	NULL
role	NULL
in	NULL
xB-specific	NULL
gene	NULL
transcription	NULL
.	NULL

The	NULL
in	NULL
vivo	NULL
role	NULL
of	NULL
Bcl-3	NULL
in	NULL
different	NULL
cell	NULL
types	NULL
is	NULL
less	NULL
clear	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
the	NULL
involvement	NULL
of	NULL
Bei-3	NULL
in	NULL
erythroid	NULL
proliferation	NULL
and	NULL
differentiation	NULL
was	NULL
investigated	NULL
using	NULL
both	NULL
an	NULL
erythroleukemia	NULL
cell	NULL
line	NULL
,	NULL
TF-1	NULL
,	NULL
``	NULL
and	NULL
normal	NULL
human	NULL
progenitor-derived	NULL
erythroblasts	NULL
.	NULL

Proliferation	NULL
of	NULL
the	NULL
TP-1	NULL
cells	NULL
is	NULL
completely	NULL
dependent	NULL
on	NULL
hematopoietic	NULL
growth	NULL
factors	NULL
,	NULL
including	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
,	NULL
erythropoietin	NULL
(	NULL
Epo	NULL
)	NULL
,	NULL
and	NULL
interleukin-3	NULL
(	NULL
IL-3	NULL
)	NULL
.	NULL
``	NULL

GM-CSF	NULL
and	NULL
Epo	NULL
stimulation	NULL
of	NULL
TF-1	NULL
proliferation	NULL
resulted	NULL
in	NULL
marked	NULL
induction	NULL
of	NULL
Bel-3	NULL
expression	NULL
.	NULL

Furthermore	NULL
,	NULL
Bel-3	NULL
was	NULL
highly	NULL
expressed	NULL
in	NULL
day-7	NULL
burst-forming	NULL
unit-erythroid	NULL
(	NULL
BFU-	NULL
From	NULL
the	NULL
Departments	NULL
of	NULL
Pediatrics	NULL
and	NULL
Microbiology	NULL
and	NULL
Immunol-ogy	NULL
,	NULL
The	NULL
Pennsylvania	NULL
State	NULL
University	NULL
College	NULL
of	NULL
Medicine	NULL
,	NULL
The	NULL
Milton	NULL
S.	NULL
Hershey	NULL
Medical	NULL
Center	NULL
,	NULL
Hershey	NULL
,	NULL
PA	NULL
.	NULL

Submitted	NULL
September	NULL
29	NULL
,	NULL
1997	NULL
;	NULL
accepted	NULL
April	NULL
17	NULL
,	NULL
1998	NULL
.	NULL

Supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grants	NULL
No	NULL
.	NULL

DK46778	NULL
(	NULL
B.A.M	NULL
.	NULL
)	NULL

,	NULL
CA	NULL
68471	NULL
(	NULL
S.-C.S	NULL
.	NULL
)	NULL

,	NULL
and	NULL
MOI	NULL
RR10732	NULL
(	NULL
GCRC	NULL
grant	NULL
)	NULL
and	NULL
by	NULL
a	NULL
grant	NULL
from	NULL
The	NULL
Pennsylvania	NULL
State	NULL
University	NULL
Cancer	NULL
Center	NULL
.	NULL

8.-C.S	NULL
.	NULL

is	NULL
a	NULL
scholar	NULL
of	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

B.A.M	NULL
.	NULL

is	NULL
the	NULL
recipient	NULL
of	NULL
an	NULL
American	NULL
Cancer	NULL
Society	NULL
Faculty	NULL
Award	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Barbara	NULL
A.	NULL
Miller	NULL
,	NULL
MD	NULL
,	NULL
Department	NULL
of	NULL
Pediatrics	NULL
,	NULL
The	NULL
Milton	NULL
S.	NULL
Hershey	NULL
Medical	NULL
Center	NULL
PO	NULL
Box	NULL
850	NULL
,	NULL
Hershey	NULL
,	NULL
PA	NULL
17033-0850	NULL
;	NULL
e-mail	NULL
:	NULL
bamll	NULL
@	NULL
psu.edu	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
adver-tisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1998	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-4971/98/9204-0021	NULL
$	NULL
3.00/0	NULL
1225	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1226	NULL
E	NULL
)	NULL
-derived	NULL
erythroid	NULL
precursors	NULL
and	NULL
decreased	NULL
with	NULL
maturation	NULL
,	NULL
suggesting	NULL
that	NULL
Bcl-3	NULL
is	NULL
involved	NULL
in	NULL
normal	NULL
erythroid	NULL
proliferation	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
previous	NULL
transfection	NULL
studies	NULL
,	NULL
``	NULL
``	NULL
endogenous	NULL
Bel-3	NULL
in	NULL
TE-1	NULL
cells	NULL
and	NULL
normal	NULL
erythroblasts	NULL
was	NULL
located	NULL
in	NULL
both	NULL
nucleus	NULL
and	NULL
cytoplasm	NULL
.	NULL

After	NULL
growth	NULL
factor	NULL
stimulation	NULL
of	NULL
TP-1	NULL
cells	NULL
,	NULL
a	NULL
gradual	NULL
but	NULL
dramatic	NULL
translocation	NULL
of	NULL
Bcel-3	NULL
to	NULL
the	NULL
nucleus	NULL
was	NULL
observed	NULL
.	NULL

Transient	NULL
transfection	NULL
studies	NULL
with	NULL
TP-1	NULL
cells	NULL
showed	NULL
that	NULL
overexpression	NULL
of	NULL
Bel-3	NULL
along	NULL
with	NULL
p50	NULL
or	NULL
p52	NULL
resulted	NULL
in	NULL
significant	NULL
transactivation	NULL
of	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
driven	NULL
by	NULL
a	NULL
human	NULL
immunodeficiency	NULL
virus-type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
xB	NULL
enhancer	NULL
,	NULL
suggesting	NULL
that	NULL
Bcl-3	NULL
can	NULL
modulate	NULL
expression	NULL
of	NULL
regulated	NULL
genes	NULL
in	NULL
vivo	NULL
in	NULL
TF-1	NULL
cells	NULL
.	NULL

Induction	NULL
of	NULL
c-myb	NULL
mRNA	NULL
was	NULL
observed	NULL
in	NULL
GM-CSE-stimulated	NULL
TF-1	NULL
cells	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
using	NULL
the	NULL
NFP-	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
of	NULL
the	NULL
c-myb	NULL
promoter	NULL
suggested	NULL
that	NULL
a	NULL
nuclear	NULL
complex	NULL
of	NULL
Bel-3	NULL
and	NULL
p52	NULL
bound	NULL
to	NULL
the	NULL
c-myb	NULL
promoter	NULL
and	NULL
this	NULL
complex	NULL
was	NULL
induced	NULL
by	NULL
GM-CSF	NULL
stimulation	NULL
of	NULL
TF-1	NULL
cells	NULL
.	NULL

Overexpression	NULL
of	NULL
Bel-3	NULL
along	NULL
with	NULL
p52	NULL
or	NULL
p50	NULL
was	NULL
also	NULL
able	NULL
to	NULL
significantly	NULL
induce	NULL
expression	NULL
of	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
driven	NULL
by	NULL
a	NULL
xB	NULL
site	NULL
present	NULL
in	NULL
the	NULL
c-myb	NULL
promoter	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
Bcel-3	NULL
may	NULL
participate	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
kB-containing	NULL
genes	NULL
involved	NULL
in	NULL
hematopoiesis	NULL
including	NULL
c-myb	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Culture	NULL
of	NULL
BFU-E-derived	NULL
erythroblasts	NULL
and	NULL
TF-1	NULL
cells	NULL
.	NULL

-	NULL
Peripheral	NULL
blood	NULL
was	NULL
obtained	NULL
from	NULL
normal	NULL
volunteer	NULL
donors	NULL
at	NULL
The	NULL
Milton	NULL
S.	NULL
Hershey	NULL
Medical	NULL
Center	NULL
(	NULL
Hershey	NULL
,	NULL
PA	NULL
)	NULL
under	NULL
protocols	NULL
approved	NULL
by	NULL
the	NULL
Institution	NULL
's	NULL
Clinical	NULL
Investigation	NULL
Committee	NULL
.	NULL

BFU-E-derived	NULL
erythroblasts	NULL
were	NULL
cultured	NULL
as	NULL
described	NULL
previously	NULL
.	NULL

'*	NULL
Briefly	NULL
,	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
were	NULL
separated	NULL
on	NULL
Ficoll-Paque	NULL
(	NULL
Pharmacia	NULL
,	NULL
Piscat-away	NULL
,	NULL
NJ	NULL
)	NULL
and	NULL
cultured	NULL
in	NULL
0.9	NULL
%	NULL
methylcellulose	NULL
media	NULL
containing	NULL
30	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
9.0	NULL
mg/mL	NULL
deionized	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
Cohn	NULL
fraction	NULL
V	NULL
;	NULL
Sigma	NULL
Chemical	NULL
Co	NULL
,	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
,	NULL
1.4	NULL
X	NULL
10~*	NULL
mol/L	NULL
B-mercaptoethanol	NULL
,	NULL
and	NULL
2	NULL
U/mL	NULL
Epo	NULL
(	NULL
recombinant	NULL
Epo	NULL
>	NULL
100,000	NULL
U/mg	NULL
;	NULL
Amgen	NULL
,	NULL
Thousand	NULL
Oaks	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Single	NULL
BFU-E	NULL
,	NULL
when	NULL
cultured	NULL
in	NULL
methylcellulose	NULL
,	NULL
proliferate	NULL
and	NULL
differentiate	NULL
over	NULL
14	NULL
days	NULL
to	NULL
form	NULL
large	NULL
colonies	NULL
containing	NULL
1	NULL
to	NULL
5	NULL
X	NULL
10*	NULL
mature	NULL
erythroblasts	NULL
.	NULL

These	NULL
cells	NULL
can	NULL
be	NULL
removed	NULL
from	NULL
culture	NULL
at	NULL
different	NULL
days	NULL
to	NULL
study	NULL
a	NULL
well-defined	NULL
population	NULL
of	NULL
normal	NULL
human	NULL
cells	NULL
at	NULL
distinct	NULL
stages	NULL
of	NULL
maturation	NULL
.	NULL
``	NULL

Day-7	NULL
cells	NULL
are	NULL
poorly	NULL
hemoglobinized	NULL
blasts	NULL
with	NULL
a	NULL
large	NULL
proliferative	NULL
capacity	NULL
,	NULL
day-10	NULL
cells	NULL
are	NULL
partially	NULL
hemoglobinized	NULL
proerythroblasts	NULL
with	NULL
decreased	NULL
proliferative	NULL
capacity	NULL
,	NULL
and	NULL
day-14	NULL
cells	NULL
are	NULL
terminally	NULL
differentiating	NULL
polychromatophilic	NULL
and	NULL
orthochromatic	NULL
normoblasts	NULL
.	NULL

Cells	NULL
from	NULL
maturing	NULL
BFU-E-derived	NULL
colonies	NULL
were	NULL
plucked	NULL
from	NULL
culture	NULL
on	NULL
days	NULL
7	NULL
,	NULL
10	NULL
,	NULL
and	NULL
14	NULL
.	NULL

Cytocentrifuge	NULL
preparations	NULL
of	NULL
aliquots	NULL
of	NULL
BFU-E-derived	NULL
cells	NULL
routinely	NULL
identified	NULL
greater	NULL
than	NULL
99	NULL
%	NULL
as	NULL
erythroid	NULL
precursors	NULL
.	NULL

TE-1	NULL
cells	NULL
,	NULL
a	NULL
human	NULL
erythroleukemia	NULL
cell	NULL
line	NULL
,	NULL
``	NULL
``	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
and	NULL
1	NULL
to	NULL
2	NULL
ng/mL	NULL
human	NULL
recombinant	NULL
GM-CSF	NULL
(	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
,	NULL
Minneapolis	NULL
,	NULL
MN	NULL
)	NULL
or	NULL
5	NULL
U/mL	NULL
Epo	NULL
.	NULL

To	NULL
examine	NULL
Bei-3	NULL
induction	NULL
,	NULL
TF-1	NULL
cells	NULL
were	NULL
removed	NULL
from	NULL
growth	NULL
factor	NULL
for	NULL
24	NULL
hours	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
2	NULL
ng/mL	NULL
GM-CSF	NULL
or	NULL
with	NULL
5	NULL
U/mL	NULL
recombinant	NULL
Epo	NULL
.	NULL

Samples	NULL
were	NULL
collected	NULL
at	NULL
intervals	NULL
over	NULL
0	NULL
to	NULL
24	NULL
hours	NULL
.	NULL

Viability	NULL
of	NULL
TF-1	NULL
cells	NULL
after	NULL
growth	NULL
factor	NULL
stimulation	NULL
was	NULL
determined	NULL
by	NULL
trypan	NULL
blue	NULL
exclusion	NULL
.	NULL

The	NULL
percentage	NULL
in	NULL
apoptosis	NULL
was	NULL
determined	NULL
with	NULL
the	NULL
ApoAlert	NULL
Annexin	NULL
V	NULL
Apoptosis	NULL
Kit	NULL
(	NULL
Clontech	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
and	NULL
analysis	NULL
with	NULL
a	NULL
fluorescence-activated	NULL
cell	NULL
sorter	NULL
.	NULL

The	NULL
cell	NULL
cycle	NULL
status	NULL
of	NULL
TF-1	NULL
cells	NULL
was	NULL
determined	NULL
by	NULL
propidium	NULL
iodide	NULL
staining	NULL
.	NULL
``	NULL

Cell	NULL
lysate	NULL
preparation	NULL
and	NULL
nuclear/cytoplasmic	NULL
fractionation	NULL
.	NULL

Whole	NULL
cell	NULL
lysates	NULL
were	NULL
prepared	NULL
by	NULL
suspending	NULL
1	NULL
X	NULL
10°	NULL
TF-1	NULL
cells	NULL
or	NULL
BFU-E-derived	NULL
erythroblasts	NULL
in	NULL
cell	NULL
lysate	NULL
buffer	NULL
(	NULL
50	NULL
mmol/L	NULL
Tris	NULL
HCJ	NULL
,	NULL
ZHANG	NULL
ET	NULL
AL	NULL
pH	NULL
8.0	NULL
,	NULL
150	NULL
mmol/L	NULL
NaCl	NULL
,	NULL
0.05	NULL
%	NULL
NP40	NULL
,	NULL
100	NULL
mmol/L	NULL
NaF	NULL
,	NULL
1	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
1	NULL
mmol/L	NULL
EGTA	NULL
,	NULL
0.08	NULL
mmol/L	NULL
phenyImethyl	NULL
sulfonyl	NULL
fluoride	NULL
[	NULL
PMSF	NULL
]	NULL
,	NULL
0.01	NULL
mg/mL	NULL
of	NULL
leupeptin	NULL
,	NULL
and	NULL
0.01	NULL
mg/mL	NULL
aprotinin	NULL
)	NULL
.	NULL

The	NULL
suspension	NULL
was	NULL
vortexed	NULL
and	NULL
centrifuged	NULL
at	NULL
10,000	NULL
rpm	NULL
for	NULL
10	NULL
minutes	NULL
.	NULL

The	NULL
supernatant	NULL
was	NULL
saved	NULL
for	NULL
Western	NULL
blotting	NULL
.	NULL

Nuclear	NULL
and	NULL
cytoplasmic	NULL
fractions	NULL
were	NULL
prepared	NULL
as	NULL
previously	NULL
described	NULL
by	NULL
Schreiber	NULL
et	NULL
al	NULL
.	NULL
'	NULL

''	NULL
TF-1	NULL
cells	NULL
(	NULL
1	NULL
X	NULL
107	NULL
)	NULL
or	NULL
BFU-E-derived	NULL
erythroblasts	NULL
(	NULL
1.5	NULL
X	NULL
10	NULL
``	NULL
)	NULL
harvested	NULL
at	NULL
day	NULL
10	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
cold	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
.	NULL

The	NULL
cell	NULL
pellet	NULL
was	NULL
resuspended	NULL
in	NULL
100	NULL
uL	NULL
of	NULL
cold	NULL
buffer	NULL
(	NULL
10	NULL
mmol/L	NULL
HEPES	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
10	NULL
mmol/L	NULL
KC	NULL
]	NULL
,	NULL
0.1	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
0.4	NULL
%	NULL
NP40	NULL
,	NULL
1	NULL
mmol/L	NULL
dithiothreitol	NULL
[	NULL
DTT	NULL
]	NULL
,	NULL
0.5	NULL
mmol/L	NULL
PMSF	NULL
,	NULL
and	NULL
1	NULL
%	NULL
volume	NULL
protease	NULL
inhibitor	NULL
cocktail	NULL
)	NULL
and	NULL
pipetted	NULL
several	NULL
times	NULL
.	NULL

The	NULL
lysates	NULL
were	NULL
spun	NULL
,	NULL
and	NULL
the	NULL
supernatant	NULL
was	NULL
used	NULL
for	NULL
the	NULL
cytosol	NULL
preparation	NULL
.	NULL

The	NULL
nuclear	NULL
pellet	NULL
was	NULL
extracted	NULL
with	NULL
50	NULL
uL	NULL
of	NULL
ice-cold	NULL
buffer	NULL
(	NULL
20	NULL
mmol/L	NULL
HEPES	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
0.4	NULL
mol/L	NULL
NaCl	NULL
,	NULL
1	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
1	NULL
mmol/L	NULL
DTT	NULL
,	NULL
and	NULL
1	NULL
mmol/L	NULL
PMSF	NULL
)	NULL
and	NULL
vigorously	NULL
shaken	NULL
for	NULL
15	NULL
minutes	NULL
at	NULL
4°C	NULL
.	NULL

After	NULL
centrifugation	NULL
,	NULL
the	NULL
nuclear	NULL
extract	NULL
was	NULL
collected	NULL
and	NULL
kept	NULL
at	NULL
-70°C	NULL
.	NULL

Human	NULL
tissues	NULL
frozen	NULL
at	NULL
-70°C	NULL
were	NULL
mixed	NULL
1:5	NULL
(	NULL
wt/vol	NULL
)	NULL
with	NULL
fresh	NULL
lysis	NULL
buffer	NULL
(	NULL
10	NULL
mmol/L	NULL
Tris	NULL
HCl	NULL
,	NULL
pH	NULL
7.6	NULL
,	NULL
5	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
5	NULL
mmol/L	NULL
MgC	NULL
)	NULL
;	NULL
,	NULL
0.8	NULL
mmol/L	NULL
PMSF	NULL
,	NULL
0.01	NULL
mg/mL	NULL
leupeptin	NULL
,	NULL
and	NULL
0.01	NULL
mg/mL	NULL
aprotinin	NULL
)	NULL
,	NULL
homogenized	NULL
,	NULL
and	NULL
centrifuged	NULL
at	NULL
10,000	NULL
rpm	NULL
for	NULL
10	NULL
minutes	NULL
.	NULL

The	NULL
supernatant	NULL
was	NULL
removed	NULL
,	NULL
quantitated	NULL
,	NULL
and	NULL
used	NULL
in	NULL
Western	NULL
blot	NULL
analysis	NULL
.	NULL

Immunoblotting	NULL
.	NULL

The	NULL
whole	NULL
cell	NULL
lysate	NULL
,	NULL
nuclear	NULL
,	NULL
or	NULL
cytoplasmic	NULL
preparations	NULL
were	NULL
boiled	NULL
for	NULL
5	NULL
minutes	NULL
in	NULL
protein	NULL
sample	NULL
buffer	NULL
and	NULL
separated	NULL
on	NULL
12	NULL
%	NULL
or	NULL
10	NULL
%	NULL
sodium	NULL
dodecyl	NULL
sulfate-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
SDS-PAGE	NULL
)	NULL
gels	NULL
.	NULL

Proteins	NULL
were	NULL
electroblotted	NULL
onto	NULL
Hybond-ECL	NULL
nitrocellulose	NULL
membrane	NULL
(	NULL
Amersham	NULL
Life	NULL
Sciences	NULL
,	NULL
Bucks	NULL
,	NULL
UK	NULL
)	NULL
according	NULL
to	NULL
the	NULL
recommended	NULL
procedures	NULL
of	NULL
the	NULL
manufac-turer	NULL
.	NULL

After	NULL
blocking	NULL
in	NULL
5	NULL
%	NULL
dry	NULL
milk	NULL
in	NULL
TBST	NULL
buffer	NULL
,	NULL
'*	NULL
membranes	NULL
then	NULL
were	NULL
incubated	NULL
with	NULL
anti-Bcl-3	NULL
antibody	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
;	NULL
diluted	NULL
1:200	NULL
)	NULL
.	NULL

Donkey	NULL
antirabbit	NULL
antibody	NULL
(	NULL
1:2,000	NULL
dilution	NULL
)	NULL
was	NULL
used	NULL
as	NULL
the	NULL
secondary	NULL
antibody	NULL
and	NULL
membranes	NULL
were	NULL
detected	NULL
with	NULL
the	NULL
ECL-Western	NULL
blotting	NULL
system	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

Preincu-bation	NULL
of	NULL
anti-Bcl-3	NULL
antibody	NULL
with	NULL
Bel-3	NULL
peptide	NULL
(	NULL
Santa	NULL
Cruz	NULL
Biotech-nology	NULL
)	NULL
competitively	NULL
removed	NULL
recognition	NULL
by	NULL
the	NULL
antibody	NULL
of	NULL
the	NULL
Bel-3	NULL
protein	NULL
band	NULL
on	NULL
Western	NULL
blots	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

As	NULL
another	NULL
control	NULL
,	NULL
an	NULL
aliquot	NULL
of	NULL
the	NULL
protein	NULL
sample	NULL
was	NULL
run	NULL
on	NULL
a	NULL
10	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
and	NULL
IxBa	NULL
protein	NULL
levels	NULL
were	NULL
examined	NULL
with	NULL
anti-IxBa	NULL
antibody	NULL
``	NULL
(	NULL
1:2,000	NULL
dilution	NULL
)	NULL
and	NULL
ECL	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
,	NULL
anti-B47	NULL
antibody	NULL
(	NULL
Santa	NULL
Cruz	NULL
;	NULL
diluted	NULL
1:250	NULL
)	NULL
was	NULL
used	NULL
to	NULL
demonstrate	NULL
subcellular	NULL
localization	NULL
of	NULL
this	NULL
basic	NULL
helix-loop-helix	NULL
transcription	NULL
factor	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
.	NULL

Total	NULL
TF-1	NULL
RNA	NULL
was	NULL
isolated	NULL
using	NULL
TRI	NULL
REAGENT-RNA/DNA/PROTEIN	NULL
isolation	NULL
reagent	NULL
(	NULL
Molecular	NULL
Research	NULL
Center	NULL
,	NULL
Inc	NULL
,	NULL
Cincinnati	NULL
,	NULL
OH	NULL
)	NULL
.	NULL

RNA	NULL
samples	NULL
(	NULL
40	NULL
ug/lane	NULL
)	NULL
were	NULL
separated	NULL
on	NULL
1.2	NULL
%	NULL
agarose-formaldehyde	NULL
gels	NULL
and	NULL
alkaline	NULL
transferred	NULL
onto	NULL
Zeta-Probe	NULL
GT	NULL
Genomic	NULL
Tested	NULL
Blotting	NULL
membrane	NULL
(	NULL
Bio-Rad	NULL
,	NULL
Hercules	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Membranes	NULL
were	NULL
prehybridized	NULL
for	NULL
5	NULL
minutes	NULL
at	NULL
42°C	NULL
in	NULL
50	NULL
%	NULL
formamide	NULL
,	NULL
120	NULL
mmol/L	NULL
250	NULL
mmol/L	NULL
NaCl	NULL
,	NULL
and	NULL
7	NULL
%	NULL
SDS	NULL
.	NULL

The	NULL
P-dCTP-labeled	NULL
Bei-3	NULL
cDNA	NULL
probe	NULL
was	NULL
added	NULL
and	NULL
the	NULL
hybridization	NULL
was	NULL
continued	NULL
for	NULL
18	NULL
hours	NULL
,	NULL
followed	NULL
by	NULL
standard	NULL
washing	NULL
steps	NULL
.	NULL

Bel-3	NULL
cDNA	NULL
clone	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
Dr	NULL
Timothy	NULL
McKeithan	NULL
,	NULL
University	NULL
of	NULL
Chicago	NULL
,	NULL
Chicago	NULL
,	NULL
IL	NULL
)	NULL
was	NULL
digested	NULL
with	NULL
EcoRI	NULL
and	NULL
HindIII	NULL
to	NULL
obtain	NULL
the	NULL
insert	NULL
,	NULL
followed	NULL
by	NULL
Geno-Bind	NULL
DNA	NULL
purification	NULL
(	NULL
Clontech	NULL
)	NULL
.	NULL

The	NULL
cDNA	NULL
probe	NULL
was	NULL
labeled	NULL
by	NULL
the	NULL
random	NULL
primer	NULL
labeling	NULL
method	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
.	NULL

Phosphatase	NULL
treatment	NULL
.	NULL

-	NULL
Whole	NULL
cell	NULL
lysates	NULL
and	NULL
nuclear/cytoplasmic	NULL
extracts	NULL
were	NULL
prepared	NULL
in	NULL
lysate	NULL
buffer	NULL
(	NULL
50	NULL
mmol/L	NULL
HEPES	NULL
,	NULL
250	NULL
mmol/L	NULL
NaCl	NULL
,	NULL
0.1	NULL
%	NULL
NP40	NULL
,	NULL
5	NULL
mmol/L	NULL
EDTA	NULL
,	NULL
1	NULL
mmol/L	NULL
DTT	NULL
,	NULL
1	NULL
mmol/L	NULL
PMSF	NULL
,	NULL
and	NULL
1	NULL
%	NULL
volume	NULL
protease	NULL
inhibitor	NULL
cocktail	NULL
)	NULL
without	NULL
any	NULL
phosphatase	NULL
inhibitors	NULL
.	NULL

Thirty	NULL
micrograms	NULL
of	NULL
protein	NULL
from	NULL
normal	NULL
human	NULL
heart	NULL
and	NULL
TF-1	NULL
cells	NULL
or	NULL
50	NULL
ug	NULL
of	NULL
protein	NULL
from	NULL
BFU-E-derived	NULL
erythroblasts	NULL
was	NULL
incubated	NULL
with	NULL
26	NULL
U	NULL
of	NULL
calf	NULL
intestine	NULL
phosphatase	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Bct-3	NULL
INDUCTION	NULL
IN	NULL
ERYTHROPOIESIS	NULL
(	NULL
CIP	NULL
;	NULL
GIBCO-BRL	NULL
,	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
)	NULL
for	NULL
40	NULL
minutes	NULL
at	NULL
37°C	NULL
and	NULL
then	NULL
separated	NULL
on	NULL
10	NULL
%	NULL
SDS-PAGE	NULL
gel	NULL
for	NULL
Western	NULL
analysis.3	NULL
TF-1	NULL
transfection	NULL
and	NULL
luciferase	NULL
assay	NULL
.	NULL

The	NULL
HIV-1	NULL
«	NULL
B-TATA-luciferase	NULL
reporter	NULL
plasmid	NULL
was	NULL
generated	NULL
by	NULL
transferring	NULL
the	NULL
insert	NULL
,	NULL
containing	NULL
the	NULL
HIV-1	NULL
xB	NULL
enhancer	NULL
and	NULL
TATA	NULL
box	NULL
,	NULL
from	NULL
the	NULL
<	NULL
B-TATA-CAT	NULL
into	NULL
the	NULL
pGL2	NULL
plasmid	NULL
5	NULL
'	NULL
of	NULL
the	NULL
luciferase	NULL
gene	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

'*	NULL
``	NULL
``	NULL
The	NULL
pGL2	NULL
basic	NULL
vector	NULL
lacking	NULL
the	NULL
TATA	NULL
box	NULL
and	NULL
the	NULL
xB	NULL
enhancer	NULL
was	NULL
used	NULL
as	NULL
a	NULL
negative	NULL
control	NULL
.	NULL

The	NULL
cDNAs	NULL
encoding	NULL
Bcl-3	NULL
,	NULL
p50	NULL
,	NULL
and	NULL
pS2	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
.	NULL

>	NULL
``	NULL
``	NULL
>	NULL
'	NULL
These	NULL
cDNAs	NULL
were	NULL
cloned	NULL
into	NULL
the	NULL
expression	NULL
plasmid	NULL
pCMV4	NULL
as	NULL
described	NULL
.	NULL

``	NULL
?	NULL

To	NULL
construct	NULL
the	NULL
c-myb	NULL
«	NULL
B-luciferase	NULL
reporter	NULL
plasmid	NULL
,	NULL
4	NULL
copies	NULL
of	NULL
a	NULL
14-nucleotide	NULL
c-myb	NULL
«	NULL
B	NULL
element	NULL
and	NULL
1	NULL
copy	NULL
of	NULL
the	NULL
Herpes	NULL
simplex	NULL
virus	NULL
thymidine	NULL
kinase	NULL
(	NULL
tk	NULL
)	NULL
minimal	NULL
promoter	NULL
were	NULL
cloned	NULL
in	NULL
front	NULL
of	NULL
a	NULL
luciferase	NULL
gene	NULL
.	NULL

In	NULL
brief	NULL
,	NULL
the	NULL
xB	NULL
oligonucleotide	NULL
sequence	NULL
present	NULL
in	NULL
the	NULL
c-myb	NULL
promoter	NULL
(	NULL
Harhaj	NULL
and	NULL
Sun	NULL
,	NULL
manuscript	NULL
in	NULL
preparation	NULL
)	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
Kpr	NULL
I/M1u	NULL
I	NULL
sites	NULL
of	NULL
the	NULL
pGL2	NULL
basic	NULL
vector	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

Subsequently	NULL
,	NULL
the	NULL
tk	NULL
promoter	NULL
was	NULL
inserted	NULL
between	NULL
the	NULL
xB	NULL
sites	NULL
and	NULL
luciferase	NULL
gene	NULL
at	NULL
the	NULL
Bgl	NULL
W/Nhe	NULL
I	NULL
sites	NULL
.	NULL

TE-1	NULL
cells	NULL
were	NULL
transfected	NULL
at	NULL
a	NULL
density	NULL
of	NULL
1	NULL
X	NULL
10°	NULL
cells/mL	NULL
with	NULL
Tfx-20	NULL
reagent	NULL
(	NULL
Promega	NULL
)	NULL
at	NULL
3:1	NULL
ratio	NULL
to	NULL
DNA	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
GM-CSF	NULL
.	NULL

The	NULL
quantity	NULL
of	NULL
reporter	NULL
gene	NULL
and	NULL
effector	NULL
plasmids	NULL
used	NULL
is	NULL
present	NULL
in	NULL
the	NULL
Results	NULL
.	NULL

After	NULL
48	NULL
hours	NULL
of	NULL
culture	NULL
,	NULL
the	NULL
transfectants	NULL
were	NULL
collected	NULL
and	NULL
suspended	NULL
in	NULL
a	NULL
lysis	NULL
buffer	NULL
(	NULL
Reporter	NULL
lysis	NULL
buffer	NULL
;	NULL
Promega	NULL
)	NULL
.	NULL

Cell	NULL
extracts	NULL
were	NULL
normalized	NULL
for	NULL
protein	NULL
recovery	NULL
(	NULL
Bio-Rad	NULL
)	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
luciferase	NULL
assay	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
quantitated	NULL
using	NULL
a	NULL
single	NULL
photon	NULL
channel	NULL
of	NULL
a	NULL
scintillation	NULL
counter	NULL
(	NULL
Beckman	NULL
,	NULL
Fullerton	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
.	NULL

EMSA	NULL
was	NULL
performed	NULL
by	NULL
the	NULL
method	NULL
described	NULL
previously	NULL
.	NULL
``	NULL

A	NULL
double-stranded	NULL
oligonucleotide	NULL
covering	NULL
a	NULL
xB	NULL
site	NULL
present	NULL
in	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
human	NULL
c-myb	NULL
gene	NULL
(	NULL
Harhaj	NULL
and	NULL
Sun	NULL
,	NULL
manuscript	NULL
in	NULL
preparation	NULL
)	NULL
was	NULL
labeled	NULL
as	NULL
described	NULL
by	NULL
Ganchi	NULL
et	NULL
al	NULL
.	NULL
``	NULL

''	NULL
Four	NULL
microliters	NULL
(	NULL
6	NULL
ug	NULL
)	NULL
of	NULL
nuclear	NULL
extracts	NULL
was	NULL
incubated	NULL
with	NULL
0.5	NULL
to	NULL
2	NULL
uL	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
anti-p50	NULL
,	NULL
anti-p52	NULL
,	NULL
anti-p65	NULL
,	NULL
anti-ReIB	NULL
,	NULL
and	NULL
anti-c-Rel	NULL
;	NULL
from	NULL
Dr	NULL
Warner	NULL
Greene	NULL
,	NULL
University	NULL
of	NULL
California	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
and	NULL
San	NULL
Francisco	NULL
General	NULL
Hospital	NULL
)	NULL
or	NULL
anti-Bcl-3	NULL
antibodies	NULL
in	NULL
12	NULL
uL	NULL
of	NULL
the	NULL
binding	NULL
buffer	NULL
(	NULL
0.5	NULL
uL	NULL
of	NULL
1	NULL
ug/uL	NULL
polydl-dC	NULL
,	NULL
1	NULL
uL	NULL
of	NULL
0.1	NULL
mol/L	NULL
DTT	NULL
,	NULL
3	NULL
uL	NULL
of	NULL
KCl-Dialysis	NULL
buffer	NULL
lacking	NULL
KCI	NULL
,	NULL
12	NULL
uL	NULL
H	NULL
;	NULL
O	NULL
)	NULL
for	NULL
10	NULL
minutes	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Following	NULL
this	NULL
,	NULL
1	NULL
uL	NULL
of	NULL
P-radiolabeled	NULL
e-myb-	NULL
«	NULL
B	NULL
probe	NULL
(	NULL
1	NULL
X	NULL
10°	NULL
cpm	NULL
)	NULL
was	NULL
added	NULL
and	NULL
incubated	NULL
for	NULL
another	NULL
25	NULL
minutes	NULL
.	NULL

The	NULL
DNA-protein	NULL
complex	NULL
was	NULL
resolved	NULL
on	NULL
a	NULL
5	NULL
%	NULL
native	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

RESULTS	NULL
GM-CSF	NULL
and	NULL
Epo	NULL
induce	NULL
Bcl-3	NULL
expression	NULL
in	NULL
TF-1	NULL
cells	NULL
.	NULL

To	NULL
explore	NULL
the	NULL
potential	NULL
role	NULL
of	NULL
the	NULL
proto-oncogene	NULL
Be/-3	NULL
in	NULL
hematopoietic	NULL
growth	NULL
factor-stimulated	NULL
proliferation	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
Bel-3	NULL
was	NULL
investigated	NULL
by	NULL
Western	NULL
blotting	NULL
analysis	NULL
in	NULL
GM-CSF-stimulated	NULL
and	NULL
Epo-stimulated	NULL
TF-1	NULL
cells	NULL
.	NULL

The	NULL
proliferation	NULL
of	NULL
TF-1	NULL
cells	NULL
is	NULL
dependent	NULL
on	NULL
growth	NULL
factors	NULL
,	NULL
including	NULL
GM-CSF	NULL
,	NULL
Epo	NULL
,	NULL
and	NULL
IL-3	NULL
,	NULL
but	NULL
the	NULL
molecular	NULL
mechanisms	NULL
by	NULL
which	NULL
these	NULL
hematopoietic	NULL
growth	NULL
factors	NULL
induce	NULL
the	NULL
growth	NULL
of	NULL
Fig	NULL
1	NULL
.	NULL

Bcl-3	NULL
expression	NULL
in	NULL
GM-CSF-stimulated	NULL
and	NULL
Epo-stimulated	NULL
TF-1	NULL
cells	NULL
.	NULL

Whole	NULL
cell	NULL
lysates	NULL
were	NULL
prepared	NULL
from	NULL
growth	NULL
factor-induced	NULL
TF-1	NULL
cells	NULL
at	NULL
the	NULL
time	NULL
points	NULL
indicated	NULL
.	NULL

Thirty	NULL
micrograms	NULL
of	NULL
protein	NULL
was	NULL
loaded	NULL
on	NULL
each	NULL
lane	NULL
of	NULL
a	NULL
12	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
(	NULL
Bel-3	NULL
)	NULL
or	NULL
15	NULL
ug	NULL
of	NULL
protein	NULL
was	NULL
loaded	NULL
on	NULL
each	NULL
lane	NULL
of	NULL
a	NULL
10	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
(	NULL
IxBa	NULL
)	NULL
.	NULL

The	NULL
membranes	NULL
were	NULL
blotted	NULL
with	NULL
anti-Bcl-3	NULL
(	NULL
1:200	NULL
)	NULL
or	NULL
anti-l	NULL
«	NULL
Ba	NULL
(	NULL
1:2,000	NULL
)	NULL
antibody	NULL
as	NULL
a	NULL
control	NULL
and	NULL
then	NULL
detected	NULL
with	NULL
ECL	NULL
.	NULL

N.D.	NULL
indicates	NULL
time	NULL
points	NULL
that	NULL
were	NULL
not	NULL
done	NULL
.	NULL

Three	NULL
independent	NULL
experiments	NULL
showed	NULL
induction	NULL
of	NULL
Bel-3	NULL
expression	NULL
.	NULL

GM-CSF	NULL
EPO	NULL
1227	NULL
TF-1	NULL
cells	NULL
have	NULL
only	NULL
been	NULL
partially	NULL
identified	NULL
.	NULL

TF-1	NULL
cells	NULL
were	NULL
growth	NULL
factor	NULL
deprived	NULL
for	NULL
24	NULL
hours	NULL
.	NULL

The	NULL
viability	NULL
of	NULL
TF-1	NULL
cells	NULL
24	NULL
hours	NULL
after	NULL
growth	NULL
factor	NULL
deprivation	NULL
was	NULL
greater	NULL
than	NULL
97	NULL
%	NULL
,	NULL
and	NULL
less	NULL
than	NULL
5	NULL
%	NULL
of	NULL
apoptotic	NULL
cells	NULL
were	NULL
detected	NULL
.	NULL

After	NULL
growth	NULL
factor	NULL
deprivation	NULL
,	NULL
2	NULL
ng/mL	NULL
of	NULL
GM-CSF	NULL
or	NULL
5	NULL
U/mL	NULL
of	NULL
Epo	NULL
was	NULL
added	NULL
to	NULL
the	NULL
medium	NULL
to	NULL
induce	NULL
cells	NULL
to	NULL
proliferate	NULL
and	NULL
the	NULL
cells	NULL
were	NULL
subsequently	NULL
continuously	NULL
stimulated	NULL
by	NULL
growth	NULL
factor	NULL
.	NULL

At	NULL
different	NULL
time	NULL
points	NULL
,	NULL
stimulated	NULL
TF-1	NULL
cells	NULL
were	NULL
collected	NULL
for	NULL
analysis	NULL
of	NULL
Bel-3	NULL
expression	NULL
.	NULL

Bel-3	NULL
protein	NULL
was	NULL
markedly	NULL
induced	NULL
after	NULL
GM-CSF	NULL
or	NULL
Epo	NULL
stimulation	NULL
(	NULL
Fig	NULL
1	NULL
)	NULL
.	NULL

At	NULL
2	NULL
hours	NULL
(	NULL
GM-CSF	NULL
)	NULL
or	NULL
4	NULL
hours	NULL
(	NULL
Epo	NULL
)	NULL
of	NULL
stimulation	NULL
,	NULL
the	NULL
level	NULL
of	NULL
Bel-3	NULL
protein	NULL
was	NULL
approximately	NULL
3	NULL
times	NULL
more	NULL
than	NULL
that	NULL
in	NULL
nonstimulated	NULL
cells	NULL
.	NULL

The	NULL
level	NULL
of	NULL
Bcl-3	NULL
protein	NULL
remained	NULL
elevated	NULL
for	NULL
at	NULL
least	NULL
24	NULL
hours	NULL
after	NULL
stimulation	NULL
.	NULL

Both	NULL
higher	NULL
and	NULL
lower	NULL
molecular	NULL
weight	NULL
isoforms	NULL
of	NULL
Bcl-3	NULL
were	NULL
induced	NULL
.	NULL

Because	NULL
Bel-3	NULL
has	NULL
been	NULL
proposed	NULL
to	NULL
be	NULL
an	NULL
IxB-like	NULL
protein	NULL
,	NULL
the	NULL
expression	NULL
pattern	NULL
of	NULL
IxBa	NULL
was	NULL
also	NULL
analyzed	NULL
in	NULL
these	NULL
stimulated	NULL
TF-1	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
Bel-3	NULL
,	NULL
IxBa	NULL
did	NULL
not	NULL
show	NULL
increased	NULL
expression	NULL
in	NULL
response	NULL
to	NULL
GM-CSF	NULL
or	NULL
Epo	NULL
stimulation	NULL
(	NULL
Fig	NULL
1	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
hematopoietic	NULL
growth	NULL
factors	NULL
participate	NULL
in	NULL
regulation	NULL
of	NULL
Bel-3	NULL
expression	NULL
in	NULL
TF-1	NULL
cells	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
mechanism	NULL
underlying	NULL
the	NULL
induction	NULL
of	NULL
Bei-3	NULL
by	NULL
hematopoietic	NULL
growth	NULL
factors	NULL
,	NULL
total	NULL
RNA	NULL
was	NULL
extracted	NULL
from	NULL
TF-1	NULL
cells	NULL
after	NULL
stimulation	NULL
by	NULL
GM-CSF	NULL
or	NULL
Epo	NULL
.	NULL

Northern	NULL
blotting	NULL
showed	NULL
that	NULL
Be/-3	NULL
transcripts	NULL
increased	NULL
significantly	NULL
after	NULL
30	NULL
minutes	NULL
of	NULL
TF-1	NULL
stimulation	NULL
by	NULL
GM-CSF	NULL
and	NULL
continued	NULL
to	NULL
be	NULL
elevated	NULL
for	NULL
24	NULL
hours	NULL
(	NULL
Fig	NULL
2	NULL
)	NULL
.	NULL

This	NULL
expression	NULL
pattern	NULL
is	NULL
consistent	NULL
with	NULL
results	NULL
of	NULL
Western	NULL
blotting	NULL
.	NULL

With	NULL
Epo	NULL
,	NULL
a	NULL
similar	NULL
increase	NULL
in	NULL
Bei-3	NULL
mRNA	NULL
was	NULL
observed	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
18S	NULL
rRNA	NULL
showed	NULL
no	NULL
significant	NULL
change	NULL
(	NULL
Fig	NULL
2	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
data	NULL
suggest	NULL
that	NULL
growth	NULL
factor	NULL
stimulation	NULL
of	NULL
TE-1	NULL
proliferation	NULL
results	NULL
in	NULL
enhanced	NULL
expression	NULL
and	NULL
that	NULL
induced	NULL
Bc/-3	NULL
expression	NULL
is	NULL
mediated	NULL
at	NULL
the	NULL
level	NULL
of	NULL
transcription	NULL
.	NULL

After	NULL
growth	NULL
factor	NULL
deprivation	NULL
of	NULL
TF-1	NULL
cells	NULL
for	NULL
24	NULL
hours	NULL
,	NULL
in	NULL
3	NULL
experiments	NULL
,	NULL
55	NULL
%	NULL
to	NULL
60	NULL
%	NULL
of	NULL
cells	NULL
were	NULL
determined	NULL
to	NULL
be	NULL
in	NULL
GO/G1	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
,	NULL
and	NULL
the	NULL
rest	NULL
of	NULL
the	NULL
cells	NULL
were	NULL
in	NULL
S	NULL
or	NULL
G2/M	NULL
phase	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
cells	NULL
in	NULL
S	NULL
phase	NULL
increased	NULL
significantly	NULL
to	NULL
a	NULL
mean	NULL
peak	NULL
of	NULL
52	NULL
%	NULL
+	NULL
2	NULL
%	NULL
at	NULL
4	NULL
to	NULL
10	NULL
hours	NULL
after	NULL
growth	NULL
factor	NULL
stimulation	NULL
(	NULL
P	NULL
=	NULL
.02	NULL
)	NULL
.	NULL

The	NULL
percentage	NULL
of	NULL
cells	NULL
in	NULL
G2	NULL
and	NULL
M	NULL
phase	NULL
also	NULL
increased	NULL
significantly	NULL
,	NULL
and	NULL
the	NULL
increase	NULL
peaked	NULL
at	NULL
16	NULL
to	NULL
20	NULL
hours	NULL
after	NULL
growth	NULL
factor	NULL
stimulation	NULL
(	NULL
P	NULL
<	NULL
002	NULL
)	NULL
.	NULL

The	NULL
doubling	NULL
time	NULL
of	NULL
TF-1	NULL
cells	NULL
was	NULL
24	NULL
hours	NULL
.	NULL

No	NULL
significant	NULL
differences	NULL
were	NULL
noted	NULL
in	NULL
the	NULL
cell	NULL
cycle	NULL
status	NULL
of	NULL
cells	NULL
after	NULL
GM-CSF	NULL
compared	NULL
with	NULL
Epo	NULL
stimulation	NULL
.	NULL

It	NULL
is	NULL
noteworthy	NULL
that	NULL
the	NULL
increase	NULL
in	NULL
Bel-3	NULL
protein	NULL
and	NULL
mRNA	NULL
preceded	NULL
the	NULL
entrance	NULL
of	NULL
the	NULL
majority	NULL
of	NULL
cells	NULL
into	NULL
S	NULL
phase	NULL
,	NULL
but	NULL
in	NULL
TF-1	NULL
cells	NULL
,	NULL
Hr	NULL
.	NULL

0	NULL
-	NULL
30°	NULL
2	NULL
4	NULL
8	NULL
10	NULL
16	NULL
20	NULL
24	NULL
Bel-3	NULL
«	NULL
--	NULL
#	NULL
»	NULL
awe	NULL
«	NULL
rs	NULL
IxBu	NULL
%	NULL
*	NULL
mag—	NULL
“	NULL
ﬂ	NULL
”	NULL
--	NULL
Bel-3	NULL
--	NULL
~	NULL
>	NULL
meme	NULL
ICB	NULL
-	NULL
ug	NULL
cmm	NULL
a	NULL
R	NULL
%	NULL
*	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

ZHANG	NULL
ET	NULL
AL	NULL
Fig	NULL
2	NULL
.	NULL

GM-CSF	NULL
and	NULL
Epo	NULL
induce	NULL
Bc/-3	NULL
mRNA	NULL
expression	NULL
in	NULL
TF-1	NULL
cells	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
isolated	NULL
from	NULL
GM-CSF-induced	NULL
or	NULL
Epo-induced	NULL
TF-1	NULL
cells	NULL
and	NULL
1228	NULL
Hr	NULL
-	NULL
00	NULL
3000	NULL
200	NULL
400	NULL
80	NULL
100	NULL
160	NULL
2000	NULL
2x	NULL
Bel-3	NULL
GM-CSF	NULL
a	NULL
Po	NULL
Uo	NULL
p	NULL
.	NULL

_..	NULL
Bel-3	NULL
i	NULL
Yun	NULL
we	NULL
EPO	NULL
Bel-3	NULL
expression	NULL
did	NULL
not	NULL
correlate	NULL
with	NULL
a	NULL
specific	NULL
phase	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
.	NULL

Nuclear	NULL
expression	NULL
of	NULL
Bcl-3	NULL
is	NULL
enhanced	NULL
by	NULL
hematopoietic	NULL
growth	NULL
factors	NULL
.	NULL

-	NULL
Previously	NULL
,	NULL
transiently	NULL
transfected	NULL
Bel-3	NULL
protein	NULL
has	NULL
been	NULL
predominantly	NULL
localized	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL
``	NULL

The	NULL
N-terminal	NULL
part	NULL
of	NULL
Bcl-3	NULL
resembles	NULL
a	NULL
nuclear	NULL
localization	NULL
signal	NULL
.	NULL

Although	NULL
this	NULL
sequence	NULL
is	NULL
not	NULL
perfectly	NULL
conserved	NULL
compared	NULL
with	NULL
other	NULL
nuclear	NULL
localization	NULL
signals	NULL
,	NULL
deletion	NULL
of	NULL
this	NULL
sequence	NULL
abolished	NULL
the	NULL
nuclear	NULL
localization	NULL
of	NULL
Bel-3.2	NULL
The	NULL
subcellular	NULL
localization	NULL
of	NULL
endogenous	NULL
Bel-3	NULL
in	NULL
a	NULL
physiological	NULL
setting	NULL
,	NULL
such	NULL
as	NULL
in	NULL
hematopoietic	NULL
growth	NULL
factor-stimulated	NULL
proliferation	NULL
,	NULL
remains	NULL
unclear	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
subcellular	NULL
localization	NULL
of	NULL
Bcel-3	NULL
in	NULL
TF-1	NULL
cells	NULL
,	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
extracts	NULL
were	NULL
isolated	NULL
from	NULL
GM-CSF-induced	NULL
or	NULL
Epo-induced	NULL
cells	NULL
and	NULL
Western	NULL
blotting	NULL
analysis	NULL
was	NULL
performed	NULL
.	NULL

Bel-3	NULL
protein	NULL
was	NULL
weakly	NULL
detectable	NULL
in	NULL
both	NULL
cytoplasm	NULL
and	NULL
nucleus	NULL
before	NULL
growth	NULL
factor	NULL
stimulation	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
growth	NULL
factor	NULL
stimulation	NULL
on	NULL
the	NULL
subcellular	NULL
localization	NULL
of	NULL
Bel-3	NULL
was	NULL
determined	NULL
.	NULL

Growth	NULL
factor	NULL
stimulation	NULL
greatly	NULL
enhanced	NULL
the	NULL
level	NULL
of	NULL
cytoplasmic	NULL
Bel-3	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
addition	NULL
,	NULL
the	NULL
nuclear	NULL
level	NULL
of	NULL
Bel-3	NULL
also	NULL
was	NULL
greatly	NULL
increased	NULL
,	NULL
suggesting	NULL
that	NULL
growth	NULL
factors	NULL
enhance	NULL
Bel-3	NULL
nuclear	NULL
translocation	NULL
.	NULL

To	NULL
--	NULL
Northern	NULL
blotting	NULL
analysis	NULL
was	NULL
performed	NULL
using	NULL
40	NULL
ug	NULL
RNA	NULL
from	NULL
each	NULL
sample	NULL
.	NULL

°P-dCTP-labeled	NULL
Bc/-3	NULL
cDNA	NULL
was	NULL
used	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

18s	NULL
rRNA	NULL
is	NULL
shown	NULL
as	NULL
a	NULL
control	NULL
for	NULL
equivalent	NULL
loading	NULL
.	NULL

control	NULL
for	NULL
the	NULL
quality	NULL
of	NULL
subcellular	NULL
fractionation	NULL
,	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
extracts	NULL
were	NULL
examined	NULL
for	NULL
IxBa	NULL
and	NULL
E47	NULL
localization	NULL
.	NULL

IkBa	NULL
,	NULL
a	NULL
cytoplasmic	NULL
protein	NULL
,	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
the	NULL
nuclear	NULL
fraction	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
.	NULL

E47	NULL
,	NULL
a	NULL
basic	NULL
helix-loop-helix	NULL
transcription	NULL
factor	NULL
,	NULL
``	NULL
``	NULL
was	NULL
primarily	NULL
detected	NULL
in	NULL
the	NULL
nucleus	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
.	NULL

Bcl-3	NULL
expression	NULL
in	NULL
normal	NULL
human	NULL
erythroblasts	NULL
is	NULL
correlated	NULL
with	NULL
proliferation	NULL
.	NULL

-	NULL
The	NULL
expression	NULL
of	NULL
Bel-3	NULL
protein	NULL
was	NULL
determined	NULL
in	NULL
normal	NULL
erythroid	NULL
proliferation	NULL
and	NULL
differentiation	NULL
.	NULL

Human	NULL
BFU-E-derived	NULL
erythroid	NULL
precursors	NULL
were	NULL
removed	NULL
from	NULL
culture	NULL
on	NULL
days	NULL
7	NULL
,	NULL
10	NULL
,	NULL
and	NULL
14	NULL
of	NULL
maturation	NULL
.	NULL
``	NULL

Day-7	NULL
cells	NULL
have	NULL
a	NULL
large	NULL
proliferative	NULL
capacity	NULL
,	NULL
day-10	NULL
cells	NULL
are	NULL
only	NULL
partially	NULL
hemoglobinized	NULL
with	NULL
decreased	NULL
proliferative	NULL
capacity	NULL
,	NULL
and	NULL
day-14	NULL
cells	NULL
are	NULL
largely	NULL
terminally	NULL
differentiating	NULL
normoblasts	NULL
.	NULL

Western	NULL
blotting	NULL
assay	NULL
was	NULL
performed	NULL
using	NULL
whole	NULL
cell	NULL
lysates	NULL
from	NULL
day-7	NULL
,	NULL
-10	NULL
,	NULL
and	NULL
-14	NULL
cells	NULL
(	NULL
Fig	NULL
4A	NULL
)	NULL
.	NULL

In	NULL
day-7	NULL
cells	NULL
,	NULL
which	NULL
are	NULL
rapidly	NULL
proliferating	NULL
,	NULL
Bel-3	NULL
had	NULL
the	NULL
highest	NULL
expression	NULL
level	NULL
and	NULL
decreased	NULL
as	NULL
erythroid	NULL
precursors	NULL
terminally	NULL
differentiated	NULL
.	NULL

This	NULL
dynamic	NULL
pattern	NULL
suggests	NULL
that	NULL
Bcl-3	NULL
expression	NULL
is	NULL
associated	NULL
with	NULL
normal	NULL
erythroid	NULL
proliferation	NULL
rather	NULL
than	NULL
differentiation	NULL
.	NULL

Although	NULL
Bcel-3	NULL
was	NULL
minimally	NULL
detectable	NULL
in	NULL
day-14	NULL
cells	NULL
,	NULL
IxBa	NULL
showed	NULL
little	NULL
decline	NULL
during	NULL
differentiation	NULL
and	NULL
substantial	NULL
quantities	NULL
were	NULL
still	NULL
present	NULL
at	NULL
day	NULL
14	NULL
.	NULL

In	NULL
Nuclear	NULL
Cytoplasm	NULL
Hr	NULL
0	NULL
3000	NULL
200	NULL
400080	NULL
100	NULL
d60	NULL
2000	NULL
2	NULL
%	NULL
Hr	NULL
0	NULL
30°	NULL
200	NULL
400	NULL
800	NULL
100	NULL
160	NULL
200	NULL
2	NULL
%	NULL
Bel-3	NULL
eties	NULL
.	NULL

ams	NULL
ees	NULL
.	NULL

on	NULL
wee	NULL
com	NULL
mmm	NULL
<	NULL
e	NULL
-	NULL
eee	NULL
-mmmeaiiits	NULL
GM-CSF	NULL
TkBo	NULL
.	NULL

w	NULL
-	NULL
o	NULL
a	NULL
w	NULL
w	NULL
@	NULL
w	NULL
W	NULL
B47	NULL
white	NULL
oom	NULL
~s	NULL
«	NULL
ane	NULL
«	NULL
ih	NULL
worm	NULL
alities	NULL
muwe	NULL
C	NULL
Bel-3	NULL
%	NULL
*	NULL
EPO	NULL
|	NULL
:	NULL
IxBo	NULL
;	NULL
L	NULL
Te	NULL
RE	NULL
sue	NULL
Fig	NULL
3	NULL
.	NULL

-	NULL
GM-CSF	NULL
and	NULL
Epo	NULL
enhance	NULL
Bel-3	NULL
nuclear	NULL
translocation	NULL
.	NULL

Growth	NULL
factor-induced	NULL
TF-1	NULL
cells	NULL
(	NULL
1	NULL
x	NULL
10	NULL
``	NULL
)	NULL
were	NULL
used	NULL
for	NULL
nuclear	NULL
or	NULL
cytoplasm	NULL
separation	NULL
.	NULL

Twenty-five	NULL
micrograms	NULL
of	NULL
nuclear	NULL
or	NULL
20	NULL
g	NULL
of	NULL
cytosolic	NULL
protein	NULL
extracts	NULL
was	NULL
loaded	NULL
on	NULL
each	NULL
lane	NULL
of	NULL
a	NULL
12	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
and	NULL
subjected	NULL
to	NULL
Western	NULL
blotting	NULL
with	NULL
anti-Bcl-3	NULL
antibody	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
1	NULL
5	NULL
pg	NULL
of	NULL
nuclear	NULL
or	NULL
cytoplasmic	NULL
extract	NULL
was	NULL
loaded	NULL
on	NULL
a	NULL
10	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
to	NULL
detect	NULL
IxBa	NULL
«	NULL
.	NULL

For	NULL
GM-CSF-stimulated	NULL
cells	NULL
,	NULL
30	NULL
g	NULL
of	NULL
nuclear	NULL
or	NULL
cytoplasmic	NULL
extract	NULL
was	NULL
loaded	NULL
on	NULL
each	NULL
lane	NULL
of	NULL
12	NULL
%	NULL
gel	NULL
and	NULL
detection	NULL
was	NULL
with	NULL
anti-E47	NULL
antibody	NULL
as	NULL
another	NULL
control	NULL
for	NULL
quality	NULL
of	NULL
subcellular	NULL
fractionation	NULL
.	NULL

Representative	NULL
results	NULL
are	NULL
shown	NULL
from	NULL
3	NULL
independent	NULL
experiments	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Bct-3	NULL
INDUCTION	NULL
IN	NULL
ERYTHROPOIESIS	NULL
Fig	NULL
4	NULL
.	NULL

Bcl-3	NULL
expression	NULL
in	NULL
day-7	NULL
,	NULL
-10	NULL
,	NULL
and	NULL
-14	NULL
BFU-E-derived	NULL
erythroblasts	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Normal	NULL
human	NULL
BFU-E-derived	NULL
erythroblasts	NULL
were	NULL
harvested	NULL
and	NULL
the	NULL
whole	NULL
cell	NULL
lysates	NULL
from	NULL
4	NULL
x	NULL
10°	NULL
(	NULL
Bel-3	NULL
)	NULL
or	NULL
2	NULL
x	NULL
10°	NULL
(	NULL
IxBa	NULL
)	NULL
cells	NULL
were	NULL
separated	NULL
on	NULL
a	NULL
10	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

Western	NULL
analysis	NULL
was	NULL
performed	NULL
with	NULL
anti-Bcl-3	NULL
or	NULL
anti-l	NULL
«	NULL
Ba	NULL
antibodies	NULL
and	NULL
ECL	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Nuclear	NULL
and	NULL
cytoplasmic	NULL
extracts	NULL
were	NULL
separated	NULL
from	NULL
day-10	NULL
cells	NULL
.	NULL

Fifty	NULL
micrograms	NULL
of	NULL
nuclear	NULL
(	NULL
N	NULL
)	NULL
or	NULL
cytoplasmic	NULL
(	NULL
C	NULL
)	NULL
extract	NULL
was	NULL
loaded	NULL
onto	NULL
each	NULL
lane	NULL
of	NULL
a	NULL
10	NULL
%	NULL
gel	NULL
and	NULL
subjected	NULL
to	NULL
Western	NULL
blotting	NULL
.	NULL

Tw	NULL
o	NULL
experiments	NULL
were	NULL
performed	NULL
with	NULL
anti-Bcl-3	NULL
or	NULL
anti-l	NULL
«	NULL
Ba	NULL
antibodies	NULL
with	NULL
identical	NULL
results	NULL
.	NULL

Day	NULL
Bcel-3	NULL
IKBo	NULL
day-10	NULL
BFU-E-derived	NULL
cells	NULL
,	NULL
subcellular	NULL
localization	NULL
studies	NULL
with	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
extracts	NULL
also	NULL
showed	NULL
that	NULL
Bel-3	NULL
was	NULL
present	NULL
in	NULL
both	NULL
nucleus	NULL
and	NULL
cytoplasm	NULL
,	NULL
whereas	NULL
IxBa	NULL
was	NULL
primarily	NULL
cytoplasmic	NULL
(	NULL
Fig	NULL
4B	NULL
)	NULL
.	NULL

Bcl-3	NULL
is	NULL
hyperphosphorylated	NULL
in	NULL
TF-1	NULL
and	NULL
BFU-E-derived	NULL
erythroblasts	NULL
.	NULL

-	NULL
Bel-3	NULL
mRNA	NULL
has	NULL
previously	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
expressed	NULL
in	NULL
several	NULL
mammalian	NULL
tissues	NULL
.	NULL
``	NULL

Expression	NULL
of	NULL
Bel-3	NULL
protein	NULL
was	NULL
examined	NULL
here	NULL
in	NULL
7	NULL
human	NULL
tissues	NULL
.	NULL

Bel-3	NULL
was	NULL
highly	NULL
expressed	NULL
in	NULL
heart	NULL
,	NULL
skeletal	NULL
muscle	NULL
,	NULL
and	NULL
erythroid	NULL
precursors	NULL
;	NULL
weakly	NULL
detectable	NULL
in	NULL
liver	NULL
,	NULL
kidney	NULL
,	NULL
and	NULL
spleen	NULL
;	NULL
and	NULL
barely	NULL
detectable	NULL
in	NULL
the	NULL
brain	NULL
(	NULL
Fig	NULL
5	NULL
)	NULL
.	NULL

Parallel	NULL
Northern	NULL
blotting	NULL
(	NULL
Clontech	NULL
)	NULL
showed	NULL
that	NULL
the	NULL
pattern	NULL
of	NULL
Bel-3	NULL
protein	NULL
correlated	NULL
with	NULL
mRNA	NULL
expression	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
a	NULL
single	NULL
mRNA	NULL
band	NULL
was	NULL
observed	NULL
.	NULL

The	NULL
molecular	NULL
weight	NULL
of	NULL
Bcel-3	NULL
deduced	NULL
from	NULL
the	NULL
protein	NULL
sequence	NULL
is	NULL
47	NULL
kD	NULL
.	NULL
'	NULL

Bel-3	NULL
protein	NULL
detected	NULL
from	NULL
normal	NULL
human	NULL
tissues	NULL
such	NULL
as	NULL
heart	NULL
,	NULL
skeletal	NULL
muscle	NULL
,	NULL
spleen	NULL
,	NULL
and	NULL
liver	NULL
showed	NULL
a	NULL
slightly	NULL
higher	NULL
molecular	NULL
weight	NULL
(	NULL
Fig	NULL
5	NULL
)	NULL
.	NULL

Western	NULL
blotting	NULL
analysis	NULL
showed	NULL
multiple	NULL
isoforms	NULL
of	NULL
Bel-3	NULL
in	NULL
GM-CSF-	NULL
or	NULL
Epo-stimulated	NULL
TF-1	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
same	NULL
result	NULL
was	NULL
obtained	NULL
with	NULL
BFU-E-derived	NULL
erythroblasts	NULL
(	NULL
Figs	NULL
1	NULL
,	NULL
3	NULL
,	NULL
and	NULL
4	NULL
)	NULL
.	NULL

In	NULL
BFU-E-derived	NULL
erythroblasts	NULL
(	NULL
Fig	NULL
5	NULL
)	NULL
or	NULL
TF-1	NULL
cells	NULL
(	NULL
Fig	NULL
6	NULL
)	NULL
,	NULL
Bel-3	NULL
was	NULL
larger	NULL
than	NULL
that	NULL
in	NULL
other	NULL
human	NULL
tissues	NULL
.	NULL

It	NULL
is	NULL
known	NULL
that	NULL
Bel-3	NULL
is	NULL
a	NULL
proline-	NULL
and	NULL
serine-rich	NULL
protein	NULL
with	NULL
high	NULL
phosphorylation	NULL
potential	NULL
.	NULL
``	NULL

''	NULL
To	NULL
test	NULL
if	NULL
the	NULL
observed	NULL
heterogeneity	NULL
in	NULL
size	NULL
was	NULL
due	NULL
to	NULL
protein	NULL
phosphorylation	NULL
,	NULL
TF-1	NULL
and	NULL
BFU-E-derived	NULL
erythroblast	NULL
cells	NULL
and	NULL
normal	NULL
heart	NULL
were	NULL
treated	NULL
with	NULL
CIP	NULL
.	NULL

CIP	NULL
treatment	NULL
resulted	NULL
in	NULL
molecular	NULL
weight	NULL
reduction	NULL
of	NULL
Bel-3	NULL
in	NULL
both	NULL
TF-1	NULL
(	NULL
Fig	NULL
6	NULL
,	NULL
top	NULL
)	NULL
and	NULL
BFU-E-derived	NULL
(	NULL
Fig	NULL
6	NULL
,	NULL
bottom	NULL
)	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
CIP	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
molecular	NULL
weight	NULL
of	NULL
Bel-3	NULL
from	NULL
human	NULL
heart	NULL
tissue	NULL
.	NULL

In	NULL
Fig	NULL
6	NULL
,	NULL
the	NULL
highest	NULL
&	NULL
20	NULL
og	NULL
-	NULL
og	NULL
;	NULL
go	NULL
go	NULL
$	NULL
o	NULL
<	NULL
-	NULL
$	NULL
kDa	NULL
U	NULL
:	NULL
[	NULL
aa	NULL
]	NULL
-	NULL
]	NULL
V	NULL
$	NULL
2	NULL
66	NULL
gam	NULL
l	NULL
46	NULL
7	NULL
(	NULL
lims	NULL
Spleen	NULL
1229	NULL
10	NULL
14	NULL
molecular	NULL
weight	NULL
band	NULL
was	NULL
thought	NULL
to	NULL
represent	NULL
a	NULL
nonspecific	NULL
protein	NULL
,	NULL
because	NULL
it	NULL
was	NULL
inconsistently	NULL
observed	NULL
.	NULL

These	NULL
data	NULL
demonstrate	NULL
that	NULL
the	NULL
different	NULL
size	NULL
of	NULL
Bcl-3	NULL
protein	NULL
in	NULL
tissue	NULL
compared	NULL
with	NULL
TE-1	NULL
or	NULL
BFU-E-derived	NULL
cells	NULL
is	NULL
at	NULL
least	NULL
partially	NULL
due	NULL
to	NULL
differential	NULL
Bel-3	NULL
phosphorylation	NULL
.	NULL

GM-CSF	NULL
and	NULL
Epo	NULL
stimulated	NULL
the	NULL
appearance	NULL
of	NULL
higher	NULL
and	NULL
lower	NULL
molecular	NULL
weight	NULL
Bel-3	NULL
isoforms	NULL
(	NULL
Fig	NULL
1	NULL
)	NULL
and	NULL
both	NULL
are	NULL
found	NULL
in	NULL
TF-1	NULL
and	NULL
BFU-E	NULL
nucleus	NULL
and	NULL
cytoplasm	NULL
(	NULL
Figs	NULL
4	NULL
and	NULL
6	NULL
)	NULL
.	NULL

The	NULL
functional	NULL
significance	NULL
of	NULL
Bcl-3	NULL
hyperphosphorylation	NULL
in	NULL
these	NULL
hematopoietic-derived	NULL
cells	NULL
remains	NULL
to	NULL
be	NULL
determined	NULL
,	NULL
but	NULL
in	NULL
other	NULL
systems	NULL
Bel-3	NULL
dephosphorylation	NULL
resulted	NULL
in	NULL
decreased	NULL
activity	NULL
.	NULL

``	NULL
~	NULL
Overexpression	NULL
of	NULL
Bcl-3	NULL
in	NULL
TF-1	NULL
cells	NULL
activates	NULL
an	NULL
HIV-1	NULL
kB	NULL
To	NULL
determine	NULL
whether	NULL
Bcl-3	NULL
has	NULL
a	NULL
role	NULL
in	NULL
gene	NULL
activation	NULL
in	NULL
TF-1	NULL
cells	NULL
,	NULL
functional	NULL
reporter	NULL
gene	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
an	NULL
HIV-1	NULL
kB-TATA-luciferase	NULL
reporter	NULL
plas-mid	NULL
.	NULL
``	NULL

This	NULL
plasmid	NULL
was	NULL
cotransfected	NULL
into	NULL
proliferating	NULL
TF-1	NULL
cells	NULL
(	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
GM-CSF	NULL
)	NULL
along	NULL
with	NULL
cDNA	NULL
for	NULL
Bcl-3	NULL
,	NULL
p50	NULL
,	NULL
or	NULL
p52	NULL
.	NULL

In	NULL
these	NULL
experiments	NULL
,	NULL
indicated	NULL
amounts	NULL
of	NULL
plasmids	NULL
expressing	NULL
p50	NULL
,	NULL
52	NULL
,	NULL
or	NULL
Bcl-3	NULL
were	NULL
transfected	NULL
either	NULL
separately	NULL
or	NULL
in	NULL
combination	NULL
along	NULL
with	NULL
0.5	NULL
ug	NULL
of	NULL
HIV-1	NULL
xB-TATA-luciferase	NULL
reporter	NULL
plasmid	NULL
into	NULL
TF-1	NULL
cells	NULL
.	NULL

The	NULL
total	NULL
amount	NULL
of	NULL
transfected	NULL
DNA	NULL
(	NULL
2.0	NULL
ug	NULL
)	NULL
was	NULL
kept	NULL
constant	NULL
by	NULL
adding	NULL
appropriate	NULL
amounts	NULL
of	NULL
expression	NULL
vector	NULL
without	NULL
insert	NULL
.	NULL

The	NULL
pGL2	NULL
vector	NULL
was	NULL
transfected	NULL
as	NULL
the	NULL
negative	NULL
control	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
7	NULL
,	NULL
a	NULL
high	NULL
level	NULL
of	NULL
was	NULL
expressed	NULL
when	NULL
this	NULL
reporter	NULL
plasmid	NULL
was	NULL
transfected	NULL
alone	NULL
.	NULL

This	NULL
result	NULL
is	NULL
consistent	NULL
with	NULL
our	NULL
finding	NULL
that	NULL
endogenous	NULL
Bel-3	NULL
and	NULL
other	NULL
NE-	NULL
«	NULL
B	NULL
factors	NULL
are	NULL
induced	NULL
in	NULL
TFE-1	NULL
cells	NULL
by	NULL
the	NULL
growth	NULL
factor	NULL
GM-CSF	NULL
``	NULL
Significant	NULL
further	NULL
induction	NULL
of	NULL
luciferase	NULL
was	NULL
observed	NULL
in	NULL
TF-1	NULL
cells	NULL
cotransfected	NULL
with	NULL
the	NULL
xB-TATA	NULL
reporter	NULL
enhancer	NULL
.	NULL

Day	NULL
10	NULL
BFU-E	NULL
Fig	NULL
5	NULL
.	NULL

Bcl-3	NULL
is	NULL
expressed	NULL
in	NULL
many	NULL
human	NULL
tissues	NULL
.	NULL

Protein	NULL
extracts	NULL
from	NULL
normal	NULL
human	NULL
tissues	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Thirty	NULL
micrograms	NULL
of	NULL
protein	NULL
was	NULL
loaded	NULL
on	NULL
each	NULL
lane	NULL
of	NULL
a	NULL
10	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
and	NULL
detection	NULL
was	NULL
with	NULL
anti-Bcl-3	NULL
antibody	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1230	NULL
ZHANG	NULL
ET	NULL
AL	NULL
EPO	NULL
GM-CSF	NULL
W	NULL
N	NULL
C	NULL
N	NULL
C	NULL
W	NULL
kDa	NULL
V_V	NULL
+	NULL
-	NULL
-	NULL
+	NULL
+	NULL
-	NULL
V_V	NULL
Y	NULL
If	NULL
9	NULL
If	NULL
5-2	NULL
66	NULL
cmm	NULL
«	NULL
mittee	NULL
.	NULL

``	NULL
_Ak.s	NULL
``	NULL
``	NULL
._	NULL
``	NULL
«	NULL
a6	NULL
«	NULL
wee	NULL
<	NULL
aam	NULL
>	NULL
«	NULL
zis	NULL
m	NULL
<	NULL
<	NULL
=	NULL
Heart	NULL
Day	NULL
10	NULL
BFU-E	NULL
kDa	NULL
w	NULL
w	NULL
C	NULL
N	NULL
w	NULL
w	NULL
-	NULL
+	NULL
-	NULL
-	NULL
-	NULL
+	NULL
66	NULL
eae	NULL
``	NULL
*	NULL
*	NULL
46	NULL
Fig	NULL
6	NULL
.	NULL

Bcl-3	NULL
is	NULL
hyperphosphorylated	NULL
in	NULL
TF-1	NULL
cells	NULL
and	NULL
BFU-E-derived	NULL
erythroblasts	NULL
.	NULL

(	NULL
Top	NULL
)	NULL
Whole	NULL
cell	NULL
lysates	NULL
(	NULL
W	NULL
)	NULL
and	NULL
nuclear	NULL
(	NULL
N	NULL
)	NULL
and	NULL
cytoplasmic	NULL
(	NULL
C	NULL
)	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
Epo-induced	NULL
or	NULL
GM-CSF-induced	NULL
TF-1	NULL
cells	NULL
.	NULL

Thirty	NULL
micrograms	NULL
of	NULL
each	NULL
extract	NULL
was	NULL
incubated	NULL
with	NULL
or	NULL
without	NULL
26	NULL
U	NULL
of	NULL
CIP	NULL
at	NULL
37°C	NULL
for	NULL
40	NULL
minutes	NULL
and	NULL
then	NULL
subjected	NULL
to	NULL
Western	NULL
blotting	NULL
assay	NULL
with	NULL
anti-Bcl-3	NULL
antibody	NULL
and	NULL
ECL	NULL
.	NULL

(	NULL
Bottom	NULL
)	NULL
Thirty	NULL
micrograms	NULL
of	NULL
w	NULL
hole	NULL
cell	NULL
lysate	NULL
(	NULL
W	NULL
)	NULL
from	NULL
normal	NULL
human	NULL
heart	NULL
tissue	NULL
or	NULL
50	NULL
g	NULL
from	NULL
day-10	NULL
BFU-E-derived	NULL
erythroblasts	NULL
w	NULL
as	NULL
also	NULL
incubated	NULL
with	NULL
or	NULL
without	NULL
26	NULL
U	NULL
CIP	NULL
and	NULL
subjected	NULL
to	NULL
Western	NULL
blotting	NULL
with	NULL
anti-Bcl-3	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Three	NULL
experiments	NULL
were	NULL
performed	NULL
with	NULL
similar	NULL
results	NULL
.	NULL

(	NULL
+	NULL
)	NULL
with	NULL
CIP	NULL
;	NULL
(	NULL
-	NULL
)	NULL
without	NULL
CIP	NULL
.	NULL

plasmid	NULL
and	NULL
Bel-3	NULL
together	NULL
with	NULL
p50	NULL
or	NULL
p52	NULL
(	NULL
P	NULL
<	NULL
.05	NULL
)	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
both	NULL
endogenously	NULL
expressed	NULL
and	NULL
transfected	NULL
Bel-3	NULL
and	NULL
NF-KB	NULL
factors	NULL
p50	NULL
or	NULL
p52	NULL
are	NULL
capable	NULL
of	NULL
positively	NULL
stimulating	NULL
gene	NULL
expression	NULL
from	NULL
the	NULL
HIV-1	NULL
kB	NULL
enhancer	NULL
in	NULL
TF-1	NULL
cells	NULL
.	NULL

In	NULL
control	NULL
experiments	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
1.5	NULL
ug	NULL
of	NULL
plasmid	NULL
expressing	NULL
NP-	NULL
«	NULL
B	NULL
factors	NULL
p50	NULL
or	NULL
p52	NULL
was	NULL
cotransfected	NULL
with	NULL
0.5	NULL
ug	NULL
of	NULL
HIV-1	NULL
«	NULL
kB-TATA-luciferase	NULL
reporter	NULL
plasmid	NULL
in	NULL
TP-1	NULL
cells	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
not	NULL
significantly	NULL
different	NULL
from	NULL
cotransfection	NULL
with	NULL
the	NULL
reporter	NULL
plasmid	NULL
alone	NULL
.	NULL

Bcl-3	NULL
binds	NULL
to	NULL
and	NULL
transactivates	NULL
a	NULL
kB	NULL
site	NULL
in	NULL
the	NULL
c-myb	NULL
promoter	NULL
.	NULL

-	NULL
Previous	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
transiently	NULL
transfected	NULL
Bcl-3	NULL
or	NULL
purified	NULL
Bel-3	NULL
proteins	NULL
interact	NULL
with	NULL
both	NULL
p50	NULL
and	NULL
p52	NULL
subunits	NULL
of	NULL
NF-	NULL
«	NULL
B/Rel	NULL
proteins	NULL
.	NULL

>	NULL
``	NULL
**	NULL
``	NULL
``	NULL
Depending	NULL
on	NULL
experimental	NULL
conditions	NULL
,	NULL
different	NULL
functional	NULL
results	NULL
have	NULL
been	NULL
reported	NULL
.	NULL

Bel-3	NULL
protein	NULL
has	NULL
been	NULL
observed	NULL
to	NULL
either	NULL
inhibit	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
NF-kB	NULL
p50	NULL
and	NULL
p52	NULL
in	NULL
vitro	NULL
``	NULL
or	NULL
facilitate	NULL
p52	NULL
or	NULL
p50	NULL
activity	NULL
by	NULL
forming	NULL
a	NULL
complex	NULL
with	NULL
these	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
on	NULL
DNA	NULL
.	NULL

**	NULL
``	NULL
°	NULL
To	NULL
examine	NULL
the	NULL
role	NULL
of	NULL
Bcl-3	NULL
in	NULL
xB	NULL
binding	NULL
under	NULL
physiological	NULL
conditions	NULL
,	NULL
the	NULL
interaction	NULL
of	NULL
endogeneous	NULL
Bel-3	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factors	NULL
in	NULL
growth	NULL
factor-stimulated	NULL
TF-1	NULL
cells	NULL
was	NULL
examined	NULL
.	NULL

EMSA	NULL
was	NULL
performed	NULL
using	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
that	NULL
recently	NULL
was	NULL
identified	NULL
from	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
the	NULL
human	NULL
c-myb	NULL
gene	NULL
and	NULL
nuclear	NULL
extracts	NULL
from	NULL
TF-1	NULL
cells	NULL
stimulated	NULL
with	NULL
GM-CSF	NULL
for	NULL
24	NULL
hours	NULL
.	NULL

This	NULL
site	NULL
was	NULL
chosen	NULL
because	NULL
induction	NULL
of	NULL
c-myb	NULL
mRNA	NULL
in	NULL
response	NULL
to	NULL
GM-CSF	NULL
stimulation	NULL
was	NULL
observed	NULL
in	NULL
these	NULL
TF-1	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
c-myb	NULL
has	NULL
previously	NULL
been	NULL
shown	NULL
to	NULL
have	NULL
an	NULL
important	NULL
role	NULL
in	NULL
erythropoiesis	NULL
.	NULL
``	NULL

''	NULL
``	NULL
``	NULL
Three	NULL
major	NULL
protein/	NULL
DNA	NULL
complexes	NULL
were	NULL
detected	NULL
(	NULL
Fig	NULL
8	NULL
,	NULL
C1	NULL
,	NULL
C2	NULL
,	NULL
and	NULL
C3	NULL
)	NULL
.	NULL

Antibody	NULL
supershift	NULL
assays	NULL
showed	NULL
that	NULL
all	NULL
3	NULL
complexes	NULL
,	NULL
C1	NULL
,	NULL
C2	NULL
,	NULL
and	NULL
C3	NULL
,	NULL
immunoreacted	NULL
with	NULL
the	NULL
anti-p52	NULL
antibody	NULL
.	NULL

The	NULL
anti-p50	NULL
antibody	NULL
supershifted	NULL
both	NULL
C2	NULL
and	NULL
C3	NULL
complexes	NULL
,	NULL
whereas	NULL
anti-p65	NULL
(	NULL
RelA	NULL
)	NULL
supershifted	NULL
the	NULL
C2	NULL
complex	NULL
.	NULL

None	NULL
of	NULL
these	NULL
complexes	NULL
was	NULL
immunoreactive	NULL
with	NULL
antibodies	NULL
for	NULL
RelB	NULL
or	NULL
c-Rel	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
p50	NULL
and	NULL
p52	NULL
bind	NULL
to	NULL
the	NULL
NE-	NULL
«	NULL
B	NULL
site	NULL
as	NULL
either	NULL
homodimers	NULL
or	NULL
heterodimers	NULL
with	NULL
each	NULL
other	NULL
or	NULL
with	NULL
p65	NULL
.	NULL

Formation	NULL
of	NULL
the	NULL
C1	NULL
complex	NULL
was	NULL
reproducibly	NULL
inhibited	NULL
by	NULL
anti-Bcl-3	NULL
antibody	NULL
,	NULL
suggesting	NULL
that	NULL
Bel-3	NULL
is	NULL
a	NULL
part	NULL
of	NULL
this	NULL
complex	NULL
,	NULL
which	NULL
is	NULL
also	NULL
composed	NULL
of	NULL
p52	NULL
.	NULL

In	NULL
nonstimulated	NULL
TF-1	NULL
cells	NULL
,	NULL
the	NULL
C1	NULL
complex	NULL
containing	NULL
Bel-3	NULL
and	NULL
p52	NULL
was	NULL
much	NULL
weaker	NULL
than	NULL
that	NULL
detected	NULL
in	NULL
induced	NULL
cells	NULL
(	NULL
Fig	NULL
8B	NULL
)	NULL
.	NULL

These	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
hypothesis	NULL
that	NULL
induction	NULL
of	NULL
Bcl-3	NULL
expression	NULL
by	NULL
GM-CSF	NULL
contributes	NULL
to	NULL
enhancement	NULL
of	NULL
Bcl-3	NULL
DNA	NULL
binding	NULL
and	NULL
increased	NULL
formation	NULL
of	NULL
C1	NULL
.	NULL

To	NULL
further	NULL
examine	NULL
whether	NULL
Bel-3	NULL
has	NULL
a	NULL
role	NULL
in	NULL
regulating	NULL
c-myb	NULL
expression	NULL
,	NULL
the	NULL
c-myb	NULL
xB-TATA-luciferase	NULL
plasmid	NULL
was	NULL
cotransfected	NULL
into	NULL
proliferating	NULL
TF-1	NULL
cells	NULL
(	NULL
cultured	NULL
with	NULL
GM-CSF	NULL
)	NULL
along	NULL
with	NULL
cDNA	NULL
for	NULL
Bel-3	NULL
,	NULL
p50	NULL
,	NULL
or	NULL
p52	NULL
.	NULL

Methods	NULL
are	NULL
as	NULL
described	NULL
for	NULL
the	NULL
HIV-1	NULL
«	NULL
B-TATA-luciferase	NULL
reporter	NULL
plasmid	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Bct-3	NULL
INDUCTION	NULL
IN	NULL
ERYTHROPOIESIS	NULL
Luciferase	NULL
Activity	NULL
(	NULL
x10°	NULL
)	NULL
HIV-1	NULL
«	NULL
B-TATA-lue	NULL
Fig	NULL
7	NULL
.	NULL

Activation	NULL
of	NULL
an	NULL
HIV-1	NULL
«	NULL
B-TATA-luciferase	NULL
reporter	NULL
plasmid	NULL
after	NULL
overexpression	NULL
of	NULL
Bcl-3	NULL
in	NULL
TF-1	NULL
cells	NULL
.	NULL

A	NULL
total	NULL
of	NULL
0.5	NULL
pg	NULL
of	NULL
plasmids	NULL
expressing	NULL
Bcl-3	NULL
,	NULL
p50	NULL
,	NULL
or	NULL
p52	NULL
was	NULL
cotransfected	NULL
with	NULL
0.5	NULL
ug	NULL
of	NULL
the	NULL
HIV-1	NULL
«	NULL
B-TATA-luciferase	NULL
reporter	NULL
plasmid	NULL
into	NULL
TF-1	NULL
cells	NULL
separately	NULL
or	NULL
in	NULL
combination	NULL
.	NULL

The	NULL
pGL2	NULL
basic	NULL
vector	NULL
(	NULL
0.5	NULL
ug	NULL
)	NULL
was	NULL
used	NULL
as	NULL
negative	NULL
control	NULL
.	NULL

Where	NULL
noted	NULL
,	NULL
1.0	NULL
mg	NULL
of	NULL
Bcl-3	NULL
was	NULL
cotransfected	NULL
.	NULL

The	NULL
total	NULL
amount	NULL
of	NULL
transfected	NULL
DNA	NULL
was	NULL
kept	NULL
constant	NULL
by	NULL
adding	NULL
appropriate	NULL
amounts	NULL
of	NULL
expression	NULL
vector	NULL
without	NULL
insert	NULL
.	NULL

At	NULL
48	NULL
hours	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
collected	NULL
for	NULL
luciferase	NULL
assay	NULL
.	NULL

Results	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
mean	NULL
+	NULL
SEM	NULL
(	NULL
x10°	NULL
com	NULL
)	NULL
.	NULL

Five	NULL
experiments	NULL
were	NULL
performed	NULL
.	NULL

*	NULL
A	NULL
significant	NULL
increase	NULL
above	NULL
the	NULL
«	NULL
B-TATA	NULL
reporter	NULL
plasmid	NULL
(	NULL
P=	NULL
.05	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
9	NULL
,	NULL
significant	NULL
levels	NULL
of	NULL
c-myb	NULL
kB-TATA-luciferase	NULL
were	NULL
expressed	NULL
when	NULL
this	NULL
reporter	NULL
plasmid	NULL
was	NULL
transfected	NULL
alone	NULL
.	NULL

This	NULL
is	NULL
consistent	NULL
with	NULL
our	NULL
finding	NULL
that	NULL
Bel-3	NULL
and	NULL
other	NULL
NF-kB	NULL
factors	NULL
are	NULL
induced	NULL
by	NULL
GM-CSF®	NULL
and	NULL
that	NULL
significant	NULL
amounts	NULL
of	NULL
c-myb	NULL
mRNA	NULL
are	NULL
present	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

A	NULL
significant	NULL
induction	NULL
of	NULL
luciferase	NULL
was	NULL
observed	NULL
when	NULL
the	NULL
TF-1	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
c-myb	NULL
reporter	NULL
plasmid	NULL
along	NULL
with	NULL
Bel-3	NULL
together	NULL
with	NULL
p52	NULL
or	NULL
50	NULL
(	NULL
P	NULL
=	NULL
05	NULL
)	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
endogenously	NULL
induced	NULL
and	NULL
transfected	NULL
Bel-3/NF-	NULL
«	NULL
B	NULL
factors	NULL
are	NULL
capable	NULL
of	NULL
inducing	NULL
gene	NULL
expression	NULL
from	NULL
the	NULL
c-myb	NULL
NF-B	NULL
site	NULL
in	NULL
vivo	NULL
in	NULL
TF-1	NULL
cells	NULL
.	NULL

DISCUSSION	NULL
GM-CSF	NULL
and	NULL
Epo	NULL
induce	NULL
erythroid	NULL
proliferation	NULL
by	NULL
triggering	NULL
a	NULL
cascade	NULL
of	NULL
signal	NULL
transduction	NULL
events	NULL
.	NULL

Upon	NULL
binding	NULL
to	NULL
their	NULL
specific	NULL
receptors	NULL
,	NULL
these	NULL
growth	NULL
factors	NULL
induce	NULL
activation	NULL
of	NULL
second	NULL
messengers	NULL
,	NULL
including	NULL
the	NULL
protein	NULL
tyrosine	NULL
kinase	NULL
1231	NULL
JAK2	NULL
,	NULL
Stat5	NULL
,	NULL
ras	NULL
,	NULL
Raf-1	NULL
,	NULL
and	NULL
MAP	NULL
kinase	NULL
.	NULL
``	NULL

''	NULL
``	NULL
Induction	NULL
of	NULL
these	NULL
signaling	NULL
proteins	NULL
results	NULL
in	NULL
activation	NULL
of	NULL
specific	NULL
transcription	NULL
factors	NULL
,	NULL
including	NULL
GATA-1	NULL
,	NULL
SCL	NULL
and	NULL
other	NULL
basic	NULL
helix-loop-helix	NULL
(	NULL
bHLH	NULL
)	NULL
transcription	NULL
factors	NULL
,	NULL
NF-E2	NULL
,	NULL
and	NULL
RBTN2	NULL
,	NULL
which	NULL
in	NULL
turn	NULL
control	NULL
erythroid	NULL
proliferation	NULL
and	NULL
differentiation	NULL
.	NULL

``	NULL
``	NULL
``	NULL
``	NULL
2	NULL
In	NULL
this	NULL
study	NULL
,	NULL
involvement	NULL
of	NULL
the	NULL
proto-oncogene	NULL
Be/-3	NULL
in	NULL
the	NULL
signaling	NULL
mechanisms	NULL
of	NULL
GM-CSF	NULL
and	NULL
Epo	NULL
is	NULL
demonstrated	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
Bei-3	NULL
is	NULL
greatly	NULL
enhanced	NULL
by	NULL
hematopoietic	NULL
growth	NULL
factor	NULL
stimulation	NULL
at	NULL
the	NULL
level	NULL
of	NULL
both	NULL
transcription	NULL
and	NULL
translation	NULL
.	NULL

A	NULL
dynamic	NULL
expression	NULL
pattern	NULL
of	NULL
Be/-3	NULL
in	NULL
normal	NULL
erythroid	NULL
cells	NULL
is	NULL
demonstrated	NULL
,	NULL
suggesting	NULL
that	NULL
Be/-3	NULL
is	NULL
also	NULL
involved	NULL
in	NULL
normal	NULL
erythropoiesis	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
Bei-3	NULL
by	NULL
both	NULL
GM-CSF	NULL
and	NULL
Epo	NULL
involves	NULL
enhanced	NULL
expression	NULL
of	NULL
Bel-3	NULL
mRNA	NULL
,	NULL
suggesting	NULL
that	NULL
these	NULL
growth	NULL
factors	NULL
induce	NULL
transcription	NULL
of	NULL
the	NULL
Bei-3	NULL
gene	NULL
.	NULL

A	NULL
number	NULL
of	NULL
potential	NULL
regulatory	NULL
sequences	NULL
have	NULL
been	NULL
found	NULL
in	NULL
the	NULL
5	NULL
'	NULL
-flanking	NULL
region	NULL
of	NULL
the	NULL
Bel-3	NULL
gene	NULL
.	NULL
``	NULL

These	NULL
sequences	NULL
include	NULL
binding	NULL
sites	NULL
for	NULL
Spl	NULL
,	NULL
AP-1	NULL
,	NULL
AP-2	NULL
,	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
indicating	NULL
possible	NULL
involvement	NULL
of	NULL
these	NULL
transcriptional	NULL
factors	NULL
in	NULL
regulation	NULL
of	NULL
Bei-3	NULL
gene	NULL
expression	NULL
.	NULL
``	NULL

''	NULL
In	NULL
addition	NULL
to	NULL
these	NULL
elements	NULL
,	NULL
we	NULL
observed	NULL
two	NULL
other	NULL
potential	NULL
regulatory	NULL
sequences	NULL
,	NULL
CAGCTG	NULL
and	NULL
CAACTG	NULL
.	NULL
'	NULL

These	NULL
two	NULL
DNA	NULL
sequences	NULL
are	NULL
highly	NULL
similar	NULL
to	NULL
the	NULL
E-protein	NULL
binding	NULL
site	NULL
CANNTG	NULL
,	NULL
termed	NULL
E-box	NULL
.	NULL
``	NULL

''	NULL
E-proteins	NULL
belonging	NULL
to	NULL
the	NULL
bHLH	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
form	NULL
heterodimers	NULL
with	NULL
tissue-specific	NULL
transcription	NULL
factors	NULL
such	NULL
as	NULL
SCL	NULL
,	NULL
which	NULL
then	NULL
bind	NULL
to	NULL
E-box	NULL
motifs	NULL
to	NULL
participate	NULL
in	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
genes	NULL
involved	NULL
in	NULL
cell	NULL
growth.39444	NULL
We	NULL
and	NULL
others	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
SCL	NULL
,	NULL
E47	NULL
,	NULL
and	NULL
HEB	NULL
are	NULL
involved	NULL
in	NULL
BFU-E-derived	NULL
human	NULL
erythroid	NULL
proliferation	NULL
and	NULL
GM-CSF	NULL
stimulation	NULL
of	NULL
TF-1	NULL
cells	NULL
induces	NULL
E47	NULL
expresssion	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
,	NULL
and	NULL
this	NULL
was	NULL
also	NULL
observed	NULL
for	NULL
HEB	NULL
and	NULL
E2-2	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Bel-3	NULL
transcription	NULL
is	NULL
likely	NULL
controlled	NULL
through	NULL
recognition	NULL
of	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
Bel-3	NULL
by	NULL
growth	NULL
factor-regulated	NULL
transcription	NULL
factors	NULL
involved	NULL
in	NULL
erythroid	NULL
proliferation	NULL
and	NULL
differentiation	NULL
,	NULL
which	NULL
may	NULL
include	NULL
SCL	NULL
heterodimers	NULL
.	NULL

The	NULL
studies	NULL
reported	NULL
here	NULL
demonstrate	NULL
that	NULL
endogenous	NULL
Bel-3	NULL
is	NULL
located	NULL
in	NULL
both	NULL
the	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
compartments	NULL
.	NULL

Similar	NULL
results	NULL
have	NULL
been	NULL
obtained	NULL
by	NULL
immunofluorescent	NULL
staining	NULL
of	NULL
TF-1	NULL
cells	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
are	NULL
not	NULL
in	NULL
full	NULL
agreement	NULL
with	NULL
previous	NULL
reports	NULL
in	NULL
which	NULL
the	NULL
transiently	NULL
transfected	NULL
Bcl-3	NULL
is	NULL
primarily	NULL
expressed	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

>	NULL
>	NULL
``	NULL
Such	NULL
discrepancy	NULL
suggests	NULL
that	NULL
the	NULL
nuclear	NULL
expression	NULL
of	NULL
Bcl-3	NULL
may	NULL
be	NULL
regulated	NULL
under	NULL
physiological	NULL
conditions	NULL
.	NULL

The	NULL
cytoplasmic	NULL
retention	NULL
of	NULL
endogenous	NULL
Bcl-3	NULL
in	NULL
TF-1	NULL
and	NULL
BFU-E-derived	NULL
cells	NULL
may	NULL
be	NULL
due	NULL
to	NULL
physical	NULL
association	NULL
with	NULL
other	NULL
proteins	NULL
or	NULL
to	NULL
posttranslational	NULL
modifications	NULL
.	NULL

Bcl-3	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
form	NULL
nuclear	NULL
complexes	NULL
with	NULL
NF-KB	NULL
p50	NULL
and	NULL
but	NULL
it	NULL
is	NULL
not	NULL
known	NULL
what	NULL
factors	NULL
form	NULL
cytoplasmic	NULL
complexes	NULL
with	NULL
Bel-3	NULL
.	NULL

Our	NULL
studies	NULL
also	NULL
demonstrate	NULL
that	NULL
Bel-3	NULL
is	NULL
hyperphosphorylated	NULL
in	NULL
both	NULL
TF-1	NULL
cells	NULL
and	NULL
normal	NULL
erythroblasts	NULL
.	NULL

High	NULL
and	NULL
low	NULL
molecular	NULL
weight	NULL
isoforms	NULL
are	NULL
present	NULL
in	NULL
nucleus	NULL
and	NULL
cytoplasm	NULL
;	NULL
therefore	NULL
,	NULL
the	NULL
phosphorylation	NULL
state	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
determine	NULL
subcellular	NULL
localization	NULL
.	NULL

Higher	NULL
and	NULL
lower	NULL
molecular	NULL
weight	NULL
isoforms	NULL
are	NULL
also	NULL
induced	NULL
by	NULL
growth	NULL
factor	NULL
stimulation	NULL
.	NULL

The	NULL
function	NULL
of	NULL
different	NULL
phosphorylation	NULL
states	NULL
of	NULL
Bcl-3	NULL
is	NULL
not	NULL
clear	NULL
at	NULL
this	NULL
time	NULL
.	NULL

Phosphorylation	NULL
of	NULL
Bel-3	NULL
has	NULL
previously	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
important	NULL
for	NULL
full	NULL
activity	NULL
in	NULL
other	NULL
cell	NULL
types	NULL
.	NULL

>	NULL
*	NULL
For	NULL
example	NULL
,	NULL
dephosphorylation	NULL
of	NULL
Bel-3	NULL
in	NULL
thymocytes	NULL
greatly	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1232	NULL
p50	NULL
p52	NULL
Bel-3	NULL
Antibody	NULL
:	NULL
E5	NULL
Rees	NULL
<	NULL
--	NULL
tuk	NULL
C	NULL
C2-C3-	NULL
ZHANG	NULL
ET	NULL
AL	NULL
B	NULL
m	NULL
s	NULL
w	NULL
=-	NULL
c2	NULL
ce	NULL
Hr	NULL
0	NULL
_-	NULL
24	NULL
Cl-C2-	NULL
c-	NULL
W	NULL
Wwe	NULL
Fig	NULL
8	NULL
.	NULL

-	NULL
Bcl-3	NULL
is	NULL
associated	NULL
with	NULL
NF-	NULL
«	NULL
B	NULL
p52	NULL
in	NULL
TF-1	NULL
cells	NULL
(	NULL
EMSA	NULL
)	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Six	NULL
micrograms	NULL
of	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
TF-1	NULL
cells	NULL
stimulated	NULL
with	NULL
GM-CSF	NULL
for	NULL
24	NULL
hours	NULL
was	NULL
incubated	NULL
with	NULL
different	NULL
NF-B	NULL
antibodies	NULL
for	NULL
10	NULL
minutes	NULL
before	NULL
adding	NULL
a	NULL
P-labeled	NULL
c-myb	NULL
«	NULL
B	NULL
binding	NULL
oligonuciear	NULL
probe	NULL
.	NULL

Three	NULL
DNA-protein	NULL
complexes	NULL
were	NULL
generated	NULL
.	NULL

Complexes	NULL
2	NULL
and	NULL
3	NULL
(	NULL
C2	NULL
and	NULL
C3	NULL
)	NULL
were	NULL
supershifted	NULL
by	NULL
anti-p50	NULL
;	NULL
C1	NULL
,	NULL
C2	NULL
,	NULL
and	NULL
C3	NULL
were	NULL
shifted	NULL
by	NULL
anti-p52	NULL
.	NULL

C1	NULL
was	NULL
reproducibly	NULL
inhibited	NULL
by	NULL
anti-Bcl-3	NULL
antibody	NULL
(	NULL
with	NULL
a	NULL
long	NULL
exposure	NULL
,	NULL
a	NULL
supershifted	NULL
band	NULL
was	NULL
also	NULL
visible	NULL
)	NULL
.	NULL

However	NULL
,	NULL
anti-RelB	NULL
and	NULL
anti-c-Rel	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
any	NULL
of	NULL
these	NULL
complexes	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
observed	NULL
in	NULL
3	NULL
experiments	NULL
.	NULL

(	NULL
B	NULL
)	NULL
EMSA	NULL
was	NULL
performed	NULL
with	NULL
grow	NULL
th	NULL
factor-deprived	NULL
TF-1	NULL
cells	NULL
or	NULL
TF-1	NULL
cells	NULL
induced	NULL
w	NULL
ith	NULL
GM-CSF	NULL
for	NULL
24	NULL
hours	NULL
.	NULL

The	NULL
C1	NULL
complex	NULL
was	NULL
greatly	NULL
increased	NULL
by	NULL
GM-CSF	NULL
stimulation	NULL
,	NULL
whereas	NULL
other	NULL
complexes	NULL
had	NULL
no	NULL
significant	NULL
change	NULL
.	NULL

This	NULL
experiment	NULL
was	NULL
repeated	NULL
3	NULL
times	NULL
with	NULL
similar	NULL
results	NULL
.	NULL

Luciferase	NULL
Activity	NULL
(	NULL
x104	NULL
)	NULL
4	NULL
A	NULL
L	NULL
t	NULL
t	NULL
o	NULL
tq	NULL
.	NULL

%	NULL
:	NULL
B	NULL
0	NULL
*	NULL
%	NULL
(	NULL
2	NULL
p	NULL
¢c-myb	NULL
Fig	NULL
9	NULL
.	NULL

Overexpression	NULL
of	NULL
Bcl-3	NULL
and	NULL
p50	NULL
or	NULL
p52	NULL
activates	NULL
a	NULL
c-myb	NULL
«	NULL
B-TATA-luciferase	NULL
reporter	NULL
plasmid	NULL
.	NULL

A	NULL
total	NULL
of	NULL
0.5	NULL
ug	NULL
of	NULL
plasmids	NULL
expressing	NULL
Bol-3	NULL
,	NULL
p50	NULL
,	NULL
or	NULL
p52	NULL
was	NULL
cotransfected	NULL
with	NULL
1.0	NULL
pg	NULL
of	NULL
c-myb	NULL
«	NULL
B-TATA-luciferase	NULL
reporter	NULL
plasmid	NULL
into	NULL
TF-1	NULL
cells	NULL
separately	NULL
or	NULL
in	NULL
combination	NULL
.	NULL

The	NULL
pGL2	NULL
basic	NULL
vector	NULL
was	NULL
used	NULL
as	NULL
negative	NULL
control	NULL
.	NULL

The	NULL
total	NULL
amount	NULL
of	NULL
transfected	NULL
DNA	NULL
(	NULL
2	NULL
g	NULL
)	NULL
was	NULL
kept	NULL
constant	NULL
by	NULL
adding	NULL
appropriate	NULL
amounts	NULL
of	NULL
expression	NULL
vector	NULL
without	NULL
insert	NULL
.	NULL

At	NULL
48	NULL
hours	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
collected	NULL
for	NULL
luciferase	NULL
assay	NULL
.	NULL

Results	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
mean	NULL
+	NULL
SEM	NULL
(	NULL
x10°	NULL
cpm	NULL
)	NULL
.	NULL

Three	NULL
experiments	NULL
were	NULL
performed	NULL
.	NULL

*A	NULL
significant	NULL
increase	NULL
above	NULL
the	NULL
c-myb	NULL
«	NULL
B-TATA	NULL
reporter	NULL
plasmid	NULL
(	NULL
P	NULL
<	NULL
.05	NULL
)	NULL
.	NULL

decreased	NULL
the	NULL
ability	NULL
of	NULL
Bel-3	NULL
to	NULL
augment	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
endogenous	NULL
p50	NULL
homodimers	NULL
.	NULL

*	NULL
GM-CSF	NULL
and	NULL
Epo	NULL
not	NULL
only	NULL
induce	NULL
the	NULL
expression	NULL
of	NULL
Bei-3	NULL
but	NULL
also	NULL
enhance	NULL
nuclear	NULL
translocation	NULL
upon	NULL
stimulation	NULL
of	NULL
TF-1	NULL
cells	NULL
with	NULL
these	NULL
hematopoietic	NULL
growth	NULL
factors	NULL
.	NULL

Interaction	NULL
of	NULL
Bel-3	NULL
with	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

transcription	NULL
factors	NULL
has	NULL
been	NULL
demonstrated	NULL
in	NULL
a	NULL
number	NULL
of	NULL
previous	NULL
studies	NULL
,	NULL
although	NULL
the	NULL
functional	NULL
consequences	NULL
of	NULL
these	NULL
interactions	NULL
remains	NULL
controversial	NULL
.	NULL
``	NULL

Although	NULL
some	NULL
studies	NULL
demonstrated	NULL
that	NULL
Bcl-3	NULL
inhibits	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
NF-kB	NULL
proteins	NULL
,	NULL
other	NULL
studies	NULL
showed	NULL
that	NULL
Bel-3	NULL
binds	NULL
to	NULL
a	NULL
xB	NULL
enhancer	NULL
together	NULL
with	NULL
p52	NULL
or	NULL
p50	NULL
and	NULL
serves	NULL
as	NULL
a	NULL
transcriptional	NULL
activator	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
latter	NULL
finding	NULL
,	NULL
we	NULL
demonstrated	NULL
here	NULL
that	NULL
overexpression	NULL
of	NULL
Bcl-3	NULL
along	NULL
with	NULL
p50	NULL
or	NULL
p52	NULL
in	NULL
TF-1	NULL
cells	NULL
results	NULL
in	NULL
induction	NULL
of	NULL
both	NULL
HIV-1	NULL
and	NULL
ec-myb	NULL
reporter	NULL
genes	NULL
and	NULL
that	NULL
Bel-3	NULL
has	NULL
a	NULL
function	NULL
in	NULL
gene	NULL
activation	NULL
in	NULL
vivo	NULL
in	NULL
TE-1	NULL
cells	NULL
.	NULL

These	NULL
results	NULL
provide	NULL
evidence	NULL
that	NULL
Bel-3	NULL
may	NULL
play	NULL
a	NULL
positive	NULL
role	NULL
in	NULL
transactivation	NULL
of	NULL
genes	NULL
in	NULL
erythroid	NULL
cells	NULL
.	NULL

In	NULL
TF-1	NULL
cells	NULL
,	NULL
GM-CSF	NULL
stimulates	NULL
increased	NULL
e-myb	NULL
mRNA	NULL
expression	NULL
.	NULL

We	NULL
also	NULL
present	NULL
data	NULL
that	NULL
suggest	NULL
that	NULL
Bel-3	NULL
forms	NULL
a	NULL
complex	NULL
with	NULL
NP-	NULL
«	NULL
B	NULL
p52	NULL
on	NULL
a	NULL
kB	NULL
element	NULL
present	NULL
in	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
c-myb	NULL
gene	NULL
and	NULL
that	NULL
formation	NULL
of	NULL
this	NULL
complex	NULL
is	NULL
enhanced	NULL
by	NULL
stimulation	NULL
with	NULL
GM-CSF	NULL
.	NULL

Bel-3	NULL
interaction	NULL
with	NULL
nuclear	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
,	NULL
including	NULL
p52	NULL
,	NULL
may	NULL
contribute	NULL
to	NULL
induction	NULL
of	NULL
expression	NULL
of	NULL
specific	NULL
genes	NULL
involved	NULL
in	NULL
erythroid	NULL
proliferation	NULL
,	NULL
including	NULL
e-myb	NULL
.	NULL

The	NULL
importance	NULL
of	NULL
c-myb	NULL
in	NULL
erythropoiesis	NULL
has	NULL
previously	NULL
been	NULL
demonstrated	NULL
.	NULL
``	NULL

''	NULL
``	NULL
``	NULL
The	NULL
reported	NULL
increase	NULL
in	NULL
Bel-3	NULL
in	NULL
response	NULL
to	NULL
mitogenic	NULL
signaling	NULL
,	NULL
associated	NULL
with	NULL
induction	NULL
of	NULL
immediate	NULL
genes	NULL
c-fos	NULL
and	NULL
c-myc	NULL
,	NULL
is	NULL
consistent	NULL
with	NULL
our	NULL
observations	NULL
.	NULL

!	NULL

ACKNOWLEDGMENT	NULL
The	NULL
authors	NULL
thank	NULL
Dr	NULL
Timothy	NULL
W.	NULL
McKeithan	NULL
for	NULL
providing	NULL
the	NULL
Bcel-3	NULL
cDNA	NULL
and	NULL
Dr	NULL
Warner	NULL
C.	NULL
Greene	NULL
for	NULL
the	NULL
antipeptide	NULL
specific	NULL
antisera	NULL
for	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Bct-3	NULL
INDUCTION	NULL
IN	NULL
ERYTHROPOIESIS	NULL
NF-	NULL
«	NULL
B/Rel	NULL
proteins	NULL
.	NULL

We	NULL
are	NULL
grateful	NULL
to	NULL
Dr	NULL
Toshio	NULL
Kitamura	NULL
for	NULL
providing	NULL
TF-1	NULL
cells	NULL
.	NULL

The	NULL
authors	NULL
thank	NULL
Maxine	NULL
Gerberich	NULL
for	NULL
careful	NULL
preparation	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

We	NULL
appreciate	NULL
the	NULL
technical	NULL
assistance	NULL
of	NULL
Carol	NULL
Stine	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Ohno	NULL
H	NULL
,	NULL
Takimoto	NULL
G	NULL
,	NULL
McKeithan	NULL
TW	NULL
:	NULL
The	NULL
candidate	NULL
proto-oncogene	NULL
be/-3	NULL
is	NULL
related	NULL
to	NULL
genes	NULL
implicated	NULL
in	NULL
cell	NULL
lineage	NULL
determination	NULL
and	NULL
cell	NULL
cycle	NULL
control	NULL
.	NULL

Cell	NULL
60:991	NULL
,	NULL
1990	NULL
2	NULL
.	NULL

Zhang	NULL
Q	NULL
,	NULL
Didonato	NULL
JA	NULL
,	NULL
Karin	NULL
M	NULL
,	NULL
McKeithan	NULL
TW	NULL
:	NULL
BCL3	NULL
encodes	NULL
a	NULL
nuclear	NULL
protein	NULL
which	NULL
can	NULL
alter	NULL
the	NULL
subcellular	NULL
location	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
14:3915	NULL
,	NULL
1994	NULL
3	NULL
.	NULL

Nolan	NULL
GP	NULL
,	NULL
Fujita	NULL
T	NULL
,	NULL
Bhatia	NULL
K	NULL
,	NULL
Huppi	NULL
C	NULL
,	NULL
Liou	NULL
H-C	NULL
,	NULL
Scott	NULL
ML	NULL
,	NULL
Baltimore	NULL
D	NULL
:	NULL
The	NULL
bel-3	NULL
proto-oncogene	NULL
encodes	NULL
a	NULL
nuclear	NULL
I	NULL
«	NULL
B-like	NULL
molecule	NULL
that	NULL
preferentially	NULL
interacts	NULL
with	NULL
NF-kB	NULL
p50	NULL
and	NULL
p52	NULL
in	NULL
a	NULL
phosphorylation-dependent	NULL
manner	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
13:3557	NULL
,	NULL
1993	NULL
4	NULL
.	NULL

Caamano	NULL
JH	NULL
,	NULL
Perez	NULL
P	NULL
,	NULL
Lira	NULL
SA	NULL
,	NULL
Bravo	NULL
R	NULL
:	NULL
Constitutive	NULL
expression	NULL
of	NULL
Bel-3	NULL
in	NULL
thymocytes	NULL
increases	NULL
the	NULL
DNA	NULL
binding	NULL
of	NULL
NF-kB1	NULL
(	NULL
p50	NULL
)	NULL
homodimers	NULL
in	NULL
vivo	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
16:1342	NULL
,	NULL
1996	NULL
5	NULL
.	NULL

Siebenlist	NULL
U	NULL
,	NULL
Franzoso	NULL
G	NULL
,	NULL
Brown	NULL
K	NULL
:	NULL
Structure	NULL
,	NULL
regulation	NULL
and	NULL
function	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Annu	NULL
Rev	NULL
Cell	NULL
Biol	NULL
10:405	NULL
,	NULL
1994	NULL
6	NULL
.	NULL

Liou	NULL
H-C	NULL
,	NULL
Baltimore	NULL
D	NULL
:	NULL
Regulation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
and	NULL
IxB	NULL
inhibitor	NULL
system	NULL
.	NULL

Curr	NULL
Opin	NULL
Cell	NULL
Biol	NULL
5:477	NULL
,	NULL
1993	NULL
7	NULL
.	NULL

Thanos	NULL
D	NULL
,	NULL
Maniatis	NULL
T	NULL
:	NULL
NF-kB	NULL
:	NULL
A	NULL
lesson	NULL
in	NULL
family	NULL
values	NULL
.	NULL

Cell	NULL
80:529	NULL
,	NULL
1995	NULL
8	NULL
.	NULL

Beg	NULL
AA	NULL
,	NULL
Baldwin	NULL
AS	NULL
:	NULL
The	NULL
proteins	NULL
:	NULL
Multifunctional	NULL
regulators	NULL
of	NULL
Rel/NF-	NULL
<	NULL
B	NULL
transcription	NULL
factors	NULL
.	NULL

Genes	NULL
Dev	NULL
7:2064	NULL
,	NULL
1993	NULL
9	NULL
.	NULL

Bours	NULL
V	NULL
,	NULL
Franzoso	NULL
G	NULL
,	NULL
Azarenko	NULL
V	NULL
,	NULL
Park	NULL
S	NULL
,	NULL
Kanno	NULL
T	NULL
,	NULL
Brown	NULL
K	NULL
,	NULL
Siebenlist	NULL
U	NULL
:	NULL
The	NULL
oncoprotein	NULL
Be/-3	NULL
directly	NULL
transactivates	NULL
through	NULL
«	NULL
B	NULL
motifs	NULL
via	NULL
association	NULL
with	NULL
DNA-binding	NULL
p50B	NULL
homodimers	NULL
.	NULL

Cell	NULL
72729	NULL
,	NULL
1993	NULL
10	NULL
.	NULL

Fujita	NULL
T	NULL
,	NULL
Nolan	NULL
GP	NULL
,	NULL
Liou	NULL
H-C	NULL
,	NULL
Scott	NULL
ML	NULL
,	NULL
Baltimore	NULL
D	NULL
:	NULL
The	NULL
candidate	NULL
proto-oncogene	NULL
be/-3	NULL
encodes	NULL
a	NULL
transcriptional	NULL
coactivator	NULL
that	NULL
activates	NULL
through	NULL
NF-kB	NULL
p50	NULL
homodimers	NULL
.	NULL

Genes	NULL
Dev	NULL
7:1354	NULL
,	NULL
1993	NULL
11	NULL
.	NULL

Pan	NULL
J	NULL
,	NULL
McEver	NULL
RP	NULL
:	NULL
Regulation	NULL
of	NULL
the	NULL
human	NULL
P-selection	NULL
promoter	NULL
by	NULL
Bei-3	NULL
and	NULL
specific	NULL
homodimeric	NULL
members	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B/Re	NULL
!	NULL

family	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
270:23077	NULL
,	NULL
1995	NULL
12	NULL
.	NULL

Franzoso	NULL
G	NULL
,	NULL
Bours	NULL
V	NULL
,	NULL
Azarenko	NULL
V	NULL
,	NULL
Park	NULL
S	NULL
,	NULL
Tomita-	NULL
Yamaguchi	NULL
N	NULL
,	NULL
Kanno	NULL
T	NULL
,	NULL
Brown	NULL
K	NULL
,	NULL
Sicbenlist	NULL
U	NULL
:	NULL
The	NULL
oncoprotein	NULL
Bcel-3	NULL
can	NULL
facilitate	NULL
NF-	NULL
«	NULL
B-mediated	NULL
transactivation	NULL
by	NULL
removing	NULL
inhibiting	NULL
p50	NULL
homodimers	NULL
from	NULL
select	NULL
xB	NULL
sites	NULL
.	NULL

EMBO	NULL
J	NULL
12:3893	NULL
,	NULL
1993	NULL
13	NULL
.	NULL

Kitamura	NULL
T	NULL
,	NULL
Tange	NULL
T	NULL
,	NULL
Terasawa	NULL
T	NULL
,	NULL
Chiba	NULL
S	NULL
,	NULL
Kuwaki	NULL
T	NULL
,	NULL
Miyagawa	NULL
K	NULL
,	NULL
Piao	NULL
Y-F	NULL
,	NULL
Miyazono	NULL
K	NULL
,	NULL
Urabe	NULL
A	NULL
,	NULL
Takaku	NULL
F	NULL
:	NULL
Establishment	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
unique	NULL
human	NULL
cell	NULL
line	NULL
that	NULL
proliferates	NULL
depen-dently	NULL
on	NULL
GM-CSF	NULL
,	NULL
IL-3	NULL
,	NULL
or	NULL
erythropoietin	NULL
.	NULL

J	NULL
Cell	NULL
Physiol	NULL
140:323	NULL
,	NULL
1989	NULL
14	NULL
.	NULL

Miller	NULL
BA	NULL
,	NULL
Floros	NULL
J	NULL
,	NULL
Cheung	NULL
JY	NULL
,	NULL
Wojchowski	NULL
DM	NULL
,	NULL
Bell	NULL
L	NULL
,	NULL
Begley	NULL
CG	NULL
,	NULL
Elwood	NULL
NJ	NULL
,	NULL
Kreider	NULL
J	NULL
,	NULL
Christian	NULL
C	NULL
:	NULL
Steel	NULL
factor	NULL
affects	NULL
SCL	NULL
expression	NULL
during	NULL
normal	NULL
erythroid	NULL
differentiation	NULL
.	NULL

Blood	NULL
84:2971	NULL
,	NULL
1994	NULL
15	NULL
.	NULL

Braylan	NULL
RC	NULL
,	NULL
Benson	NULL
NA	NULL
,	NULL
Noursa	NULL
V	NULL
,	NULL
Kruth	NULL
HS	NULL
:	NULL
Correlated	NULL
analyses	NULL
of	NULL
cellular	NULL
DNA	NULL
,	NULL
membrane	NULL
antigens	NULL
,	NULL
and	NULL
light	NULL
scatter	NULL
of	NULL
human	NULL
lymphoid	NULL
cells	NULL
.	NULL

Cytometry	NULL
2:337	NULL
,	NULL
1982	NULL
16	NULL
.	NULL

Schreiber	NULL
E	NULL
,	NULL
Matthias	NULL
P	NULL
,	NULL
Mullet	NULL
MM	NULL
,	NULL
Schaffner	NULL
W	NULL
:	NULL
Rapid	NULL
detection	NULL
of	NULL
octamer	NULL
binding	NULL
proteins	NULL
with	NULL
'mini-extracts	NULL
'	NULL
,	NULL
prepared	NULL
from	NULL
a	NULL
small	NULL
number	NULL
of	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
17:6419	NULL
,	NULL
1989	NULL
17	NULL
.	NULL

Sun	NULL
S-C	NULL
,	NULL
Ganchi	NULL
PA	NULL
,	NULL
Ballard	NULL
DW	NULL
,	NULL
Greene	NULL
WC	NULL
:	NULL
NF-	NULL
«	NULL
B	NULL
controls	NULL
expression	NULL
of	NULL
inhibitor	NULL
IxBa	NULL
:	NULL
Evidence	NULL
for	NULL
an	NULL
inducible	NULL
autoregulatory	NULL
pathway	NULL
.	NULL

Science	NULL
259:1912	NULL
,	NULL
1993	NULL
18	NULL
.	NULL

Stein	NULL
B	NULL
,	NULL
Rahmsdorf	NULL
H	NULL
,	NULL
Steffen	NULL
A	NULL
,	NULL
Litfin	NULL
M	NULL
,	NULL
Herrlich	NULL
P	NULL
:	NULL
UV-induced	NULL
DNA	NULL
damage	NULL
is	NULL
an	NULL
intermediate	NULL
step	NULL
in	NULL
UV-induced	NULL
expression	NULL
of	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
,	NULL
collagenase	NULL
,	NULL
c-fos	NULL
,	NULL
and	NULL
metallothionein	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
9:5169	NULL
,	NULL
1989	NULL
19	NULL
.	NULL

Sun	NULL
S-C	NULL
,	NULL
Elwood	NULL
J	NULL
,	NULL
Greene	NULL
WC	NULL
:	NULL
Both	NULL
amino-	NULL
and	NULL
carboxyl-	NULL
1233	NULL
terminal	NULL
sequences	NULL
within	NULL
IxBa	NULL
regulate	NULL
its	NULL
inducible	NULL
degradation	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
16:1058	NULL
,	NULL
1996	NULL
20	NULL
.	NULL

Ganchi	NULL
PA	NULL
,	NULL
Sun	NULL
S-C	NULL
,	NULL
Greene	NULL
WC	NULL
,	NULL
Ballard	NULL
DW	NULL
:	NULL
I	NULL
«	NULL
B/MAD-3	NULL
masks	NULL
the	NULL
nuclear	NULL
localization	NULL
signal	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
and	NULL
requires	NULL
the	NULL
transactivation	NULL
domain	NULL
to	NULL
inhibit	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
DNA	NULL
binding	NULL
.	NULL

Mol	NULL
Biol	NULL
Cell	NULL
3:1339	NULL
,	NULL
1992	NULL
21	NULL
.	NULL

Sun	NULL
S-C	NULL
,	NULL
Ganchi	NULL
PA	NULL
,	NULL
Beraud	NULL
C	NULL
,	NULL
Ballard	NULL
DW	NULL
,	NULL
Greene	NULL
WC	NULL
:	NULL
Autoregulation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
transactivator	NULL
by	NULL
multiple	NULL
ankyrin-rich	NULL
cytoplasmic	NULL
inhibitors	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
91:1346	NULL
,	NULL
1994	NULL
22	NULL
.	NULL

Maggirwar	NULL
SB	NULL
,	NULL
Harhaf	NULL
EW	NULL
,	NULL
Sun	NULL
S-C	NULL
:	NULL
Regulation	NULL
of	NULL
the	NULL
interleu-kin-2	NULL
CD28-responsive	NULL
element	NULL
by	NULL
NF-ATp	NULL
and	NULL
various	NULL
NF-	NULL
«	NULL
B/Rel	NULL
transcription	NULL
factors	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
17:2605	NULL
,	NULL
1997	NULL
23	NULL
.	NULL

Harhaj	NULL
EW	NULL
,	NULL
Maggirwar	NULL
SB	NULL
,	NULL
Good	NULL
L	NULL
,	NULL
Sun	NULL
S-C	NULL
:	NULL
CD28	NULL
mediates	NULL
a	NULL
potent	NULL
costimulatory	NULL
signal	NULL
for	NULL
rapid	NULL
degradation	NULL
of	NULL
I	NULL
«	NULL
BB	NULL
which	NULL
is	NULL
associated	NULL
with	NULL
accelerated	NULL
activation	NULL
of	NULL
various	NULL
NF-	NULL
«	NULL
B/Rel	NULL
heterodimers	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
16:6736	NULL
,	NULL
1996	NULL
24	NULL
.	NULL

Sun	NULL
S-C	NULL
,	NULL
Faye	NULL
I	NULL
:	NULL
Affinity	NULL
purification	NULL
and	NULL
characterization	NULL
of	NULL
CIF	NULL
,	NULL
an	NULL
insect	NULL
immunoresponsive	NULL
factor	NULL
with	NULL
properties	NULL
.	NULL

Comp	NULL
Biochem	NULL
Physiol	NULL
103B:225	NULL
,	NULL
1992	NULL
25	NULL
.	NULL

Condorelli	NULL
G	NULL
,	NULL
Vitelli	NULL
L	NULL
,	NULL
Valtieri	NULL
M	NULL
,	NULL
Marta	NULL
I	NULL
,	NULL
Montesoro	NULL
E	NULL
,	NULL
Lulli	NULL
V	NULL
,	NULL
Baer	NULL
R	NULL
,	NULL
Peschle	NULL
C	NULL
:	NULL
Coordinate	NULL
expression	NULL
and	NULL
developmental	NULL
role	NULL
of	NULL
Id2	NULL
protein	NULL
and	NULL
TAL1/E2A	NULL
heterodimer	NULL
in	NULL
erythroid	NULL
progenitor	NULL
differentiation	NULL
.	NULL

Blood	NULL
86:164	NULL
,	NULL
1995	NULL
26	NULL
.	NULL

Zhang	NULL
M-Y	NULL
,	NULL
Sun	NULL
S-C	NULL
,	NULL
Bell	NULL
L	NULL
,	NULL
Miller	NULL
BA	NULL
:	NULL
NF-	NULL
«	NULL
B	NULL
transcription	NULL
factors	NULL
are	NULL
involved	NULL
in	NULL
normal	NULL
erythropoiesis	NULL
.	NULL

Blood	NULL
91:4136	NULL
,	NULL
1998	NULL
27	NULL
.	NULL

Emilia	NULL
G	NULL
,	NULL
Donelli	NULL
A	NULL
,	NULL
Ferrari	NULL
S	NULL
,	NULL
Torelli	NULL
U	NULL
,	NULL
Selleri	NULL
L	NULL
,	NULL
Zucchini	NULL
P	NULL
,	NULL
Moretti	NULL
L	NULL
,	NULL
Venturelli	NULL
D	NULL
,	NULL
Ceccherelli	NULL
G	NULL
,	NULL
Torelli	NULL
G	NULL
:	NULL
Cellular	NULL
levels	NULL
of	NULL
mRNA	NULL
from	NULL
c-myc	NULL
,	NULL
c-myb	NULL
and	NULL
c-fes	NULL
onc-genes	NULL
in	NULL
normal	NULL
myeloid	NULL
and	NULL
erythroid	NULL
precursors	NULL
of	NULL
human	NULL
bone	NULL
marrow	NULL
:	NULL
An	NULL
in	NULL
situ	NULL
hybridization	NULL
study	NULL
.	NULL

Br	NULL
J	NULL
Haematol	NULL
62:287	NULL
,	NULL
1986	NULL
28	NULL
.	NULL

Caracciolo	NULL
D	NULL
,	NULL
Venturelli	NULL
D	NULL
,	NULL
Valtieri	NULL
M	NULL
,	NULL
Peschle	NULL
C	NULL
,	NULL
Gewirtz	NULL
AM	NULL
,	NULL
Calabretta	NULL
B	NULL
:	NULL
Stage-related	NULL
proliferative	NULL
activity	NULL
determines	NULL
c-myb	NULL
functional	NULL
requirements	NULL
during	NULL
normal	NULL
human	NULL
hematopoiesis	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
85:55	NULL
,	NULL
1990	NULL
29	NULL
.	NULL

Kirsch	NULL
IR	NULL
,	NULL
Bertness	NULL
V	NULL
,	NULL
Silver	NULL
J	NULL
,	NULL
Hollis	NULL
GF	NULL
:	NULL
Regulated	NULL
expression	NULL
of	NULL
the	NULL
c-myb	NULL
and	NULL
c-myc	NULL
oncogenes	NULL
during	NULL
erythroid	NULL
differentiation	NULL
.	NULL

J	NULL
Cell	NULL
Biochem	NULL
32:11	NULL
,	NULL
1986	NULL
30	NULL
.	NULL

Valtieri	NULL
M	NULL
,	NULL
Venturelli	NULL
D	NULL
,	NULL
Care	NULL
A	NULL
,	NULL
Fossati	NULL
C	NULL
,	NULL
Pelosi	NULL
E	NULL
,	NULL
Labbaye	NULL
C	NULL
,	NULL
Mattia	NULL
G	NULL
,	NULL
Gewirtz	NULL
AM	NULL
,	NULL
Calabretta	NULL
B	NULL
,	NULL
Peschle	NULL
C	NULL
:	NULL
Antisense	NULL
myb	NULL
inhibition	NULL
of	NULL
purified	NULL
erythroid	NULL
progenitors	NULL
in	NULL
development	NULL
and	NULL
differentiation	NULL
is	NULL
linked	NULL
to	NULL
cycling	NULL
activity	NULL
and	NULL
expression	NULL
of	NULL
DNA	NULL
polymerase	NULL
«	NULL
.	NULL

Blood	NULL
77:1181	NULL
,	NULL
1991	NULL
31	NULL
.	NULL

Thle	NULL
JN	NULL
,	NULL
Witthuhn	NULL
BA	NULL
,	NULL
Quelle	NULL
FW	NULL
,	NULL
Yamamoto	NULL
K	NULL
,	NULL
Silvennoinen	NULL
O	NULL
:	NULL
Signaling	NULL
through	NULL
the	NULL
hematopoietic	NULL
cytokine	NULL
receptors	NULL
.	NULL

Annu	NULL
Rev	NULL
Immunol	NULL
13:369	NULL
,	NULL
1995	NULL
32	NULL
.	NULL

Thle	NULL
JN	NULL
:	NULL
Cytokine	NULL
receptor	NULL
signalling	NULL
.	NULL

Nature	NULL
377:591	NULL
,	NULL
1995	NULL
33	NULL
.	NULL

Wakao	NULL
H	NULL
,	NULL
Harada	NULL
N	NULL
,	NULL
Kitamura	NULL
T	NULL
,	NULL
Mui	NULL
AL-F	NULL
,	NULL
Miyajima	NULL
A	NULL
:	NULL
Interleukin	NULL
2	NULL
and	NULL
erythropoietin	NULL
activate	NULL
STATS/MGF	NULL
via	NULL
distinct	NULL
pathways	NULL
.	NULL

EMBO	NULL
J	NULL
14:2527	NULL
,	NULL
1995	NULL
34	NULL
.	NULL

Gouilleux	NULL
F	NULL
,	NULL
Pallard	NULL
C	NULL
,	NULL
Dusanter-Fourt	NULL
I	NULL
,	NULL
Wakao	NULL
H	NULL
,	NULL
Haldosen	NULL
L-A	NULL
,	NULL
Norstedt	NULL
G	NULL
,	NULL
Levy	NULL
D	NULL
,	NULL
Groner	NULL
B	NULL
:	NULL
Prolactin	NULL
,	NULL
growth	NULL
hormone	NULL
,	NULL
erythropoietin	NULL
and	NULL
granulocyte-macrophage	NULL
colony	NULL
stimulating	NULL
factor	NULL
induce	NULL
MGFE-Stat5	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

EMBO	NULL
J	NULL
14:2005	NULL
,	NULL
1995	NULL
35	NULL
.	NULL

Carroll	NULL
MP	NULL
,	NULL
Spivak	NULL
JL	NULL
,	NULL
McMahon	NULL
M	NULL
,	NULL
Weich	NULL
N	NULL
,	NULL
Rapp	NULL
UR	NULL
,	NULL
May	NULL
WS	NULL
:	NULL
Erythropoietin	NULL
induces	NULL
Raf-1	NULL
activation	NULL
and	NULL
Raf-1	NULL
is	NULL
required	NULL
for	NULL
erythropoietin-mediated	NULL
proliferation	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
266:14964	NULL
,	NULL
1991	NULL
36	NULL
.	NULL

Bittorf	NULL
T	NULL
,	NULL
Jaster	NULL
R	NULL
,	NULL
Brock	NULL
J	NULL
:	NULL
Rapid	NULL
activation	NULL
of	NULL
the	NULL
MAP	NULL
kinase	NULL
pathway	NULL
in	NULL
hematopoietic	NULL
cells	NULL
by	NULL
erythropoietin	NULL
,	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
and	NULL
interleukin-3	NULL
.	NULL

Cell	NULL
Signal	NULL
6:305	NULL
,	NULL
1994	NULL
37	NULL
.	NULL

Orkin	NULL
SH	NULL
:	NULL
GATA-binding	NULL
transcription	NULL
factors	NULL
in	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Blood	NULL
80:575	NULL
,	NULL
1992	NULL
38	NULL
.	NULL

Chiba	NULL
T	NULL
,	NULL
Nagata	NULL
Y	NULL
,	NULL
Kishi	NULL
A	NULL
,	NULL
Sakamaki	NULL
K	NULL
,	NULL
Miyajima	NULL
A	NULL
,	NULL
Yamamoto	NULL
M	NULL
,	NULL
Engel	NULL
JD	NULL
,	NULL
Todokoro	NULL
K	NULL
:	NULL
Induction	NULL
of	NULL
erythroid-specific	NULL
gene	NULL
expression	NULL
in	NULL
lymphoid	NULL
cells	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
90:11593	NULL
,	NULL
1993	NULL
39	NULL
.	NULL

Robb	NULL
L	NULL
,	NULL
Lyons	NULL
I	NULL
,	NULL
Li	NULL
R	NULL
,	NULL
Hartley	NULL
L	NULL
,	NULL
Kontgen	NULL
F	NULL
,	NULL
Harvey	NULL
RP	NULL
,	NULL
Metcalf	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1234	NULL
D	NULL
,	NULL
Begley	NULL
CG	NULL
:	NULL
Absence	NULL
of	NULL
yolk	NULL
sac	NULL
hematopoiesis	NULL
from	NULL
mice	NULL
with	NULL
a	NULL
targeted	NULL
disruption	NULL
of	NULL
the	NULL
sel	NULL
gene	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
92:7075	NULL
,	NULL
1995	NULL
40	NULL
.	NULL

Zhang	NULL
M-Y	NULL
,	NULL
Clawson	NULL
GA	NULL
,	NULL
Olivieri	NULL
NF	NULL
,	NULL
Bell	NULL
LL	NULL
,	NULL
Begley	NULL
CG	NULL
,	NULL
Miller	NULL
BA	NULL
:	NULL
Expression	NULL
of	NULL
SCL	NULL
is	NULL
normal	NULL
in	NULL
transfusion-dependent	NULL
Diamond-Blackfan	NULL
anemia	NULL
but	NULL
other	NULL
bHLH	NULL
proteins	NULL
are	NULL
deficient	NULL
.	NULL

Blood	NULL
90:2068	NULL
,	NULL
1997	NULL
41	NULL
.	NULL

Andrews	NULL
NC	NULL
,	NULL
Erdjument-Bromage	NULL
H	NULL
,	NULL
Davidson	NULL
MB	NULL
,	NULL
Tempst	NULL
P	NULL
,	NULL
Orkin	NULL
SH	NULL
:	NULL
Erythroid	NULL
transcription	NULL
factor	NULL
NF-E2	NULL
is	NULL
a	NULL
haematopoictic-specific	NULL
basic-leucine	NULL
zipper	NULL
protein	NULL
.	NULL

Nature	NULL
362:722	NULL
,	NULL
1993	NULL
ZHANG	NULL
ET	NULL
AL	NULL
42	NULL
.	NULL

Osada	NULL
H	NULL
,	NULL
Grutz	NULL
G	NULL
,	NULL
Axelson	NULL
H	NULL
,	NULL
Forster	NULL
A	NULL
,	NULL
Rabbitts	NULL
TH	NULL
:	NULL
Association	NULL
of	NULL
erythroid	NULL
transcription	NULL
factors	NULL
:	NULL
Complexes	NULL
involving	NULL
the	NULL
LIM	NULL
protein	NULL
RBTN2	NULL
and	NULL
the	NULL
zinc-finger	NULL
protein	NULL
GATA1	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
92:9585	NULL
,	NULL
1995	NULL
43	NULL
.	NULL

Hsu	NULL
H-L	NULL
,	NULL
Huang	NULL
L	NULL
,	NULL
Tsan	NULL
JT	NULL
,	NULL
Funk	NULL
W	NULL
,	NULL
Wright	NULL
WE	NULL
,	NULL
Hu	NULL
J-S	NULL
,	NULL
Kingston	NULL
RE	NULL
,	NULL
Baer	NULL
R	NULL
:	NULL
Preferred	NULL
sequences	NULL
for	NULL
DNA	NULL
recognition	NULL
by	NULL
the	NULL
TAL1	NULL
helix-loop-helix	NULL
proteins	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
14:1256	NULL
,	NULL
1994	NULL
44	NULL
.	NULL

Shivdasani	NULL
RA	NULL
,	NULL
Mayer	NULL
EL	NULL
,	NULL
Orkin	NULL
SH	NULL
:	NULL
Absence	NULL
of	NULL
blood	NULL
formation	NULL
in	NULL
mice	NULL
lacking	NULL
the	NULL
T-cell	NULL
leukaemia	NULL
oncoprotein	NULL
tal-1/SCL	NULL
.	NULL

Nature	NULL
373:432	NULL
,	NULL
1995	NULL
Deoxyhemoglobin	NULL
S	NULL
crystal	NULL
.	NULL

Chromatographically	NULL
purified	NULL
HbS	NULL
(	NULL
in	NULL
5	NULL
mmol/L	NULL
KCI	NULL
,	NULL
10	NULL
mmol/L	NULL
Tris	NULL
,	NULL
pH	NULL
6.5	NULL
)	NULL
was	NULL
deoxygenated	NULL
,	NULL
air-dried	NULL
onto	NULL
a	NULL
graphite	NULL
chip	NULL
under	NULL
a	NULL
stream	NULL
of	NULL
nitrogen	NULL
,	NULL
and	NULL
examined	NULL
by	NULL
scanning	NULL
tunneling	NULL
electron	NULL
microscopy	NULL
(	NULL
STEM	NULL
)	NULL
.	NULL

Images	NULL
at	NULL
two	NULL
levels	NULL
of	NULL
resolution	NULL
are	NULL
show	NULL
n	NULL
for	NULL
a	NULL
portion	NULL
of	NULL
a	NULL
single	NULL
crystalline	NULL
bundle	NULL
of	NULL
HbS	NULL
fibers	NULL
that	NULL
was	NULL
1,450	NULL
nm	NULL
long	NULL
and	NULL
65	NULL
nm	NULL
in	NULL
diameter	NULL
.	NULL

The	NULL
size	NULL
of	NULL
the	NULL
individual	NULL
constituent	NULL
subunits	NULL
(	NULL
6	NULL
x	NULL
5	NULL
nm	NULL
)	NULL
is	NULL
consistent	NULL
with	NULL
their	NULL
identity	NULL
as	NULL
hemoglobin	NULL
tetramers	NULL
.	NULL

The	NULL
vivid	NULL
detail	NULL
at	NULL
the	NULL
interface	NULL
between	NULL
tetramers	NULL
(	NULL
asterisk	NULL
)	NULL
suggests	NULL
that	NULL
STEM	NULL
could	NULL
be	NULL
used	NULL
to	NULL
help	NULL
define	NULL
the	NULL
fine	NULL
structure	NULL
of	NULL
HbS	NULL
polymers	NULL
.	NULL

(	NULL
Courtesy	NULL
of	NULL
Mary	NULL
M.	NULL
Christopher	NULL
,	NULL
Yi	NULL
Lin	NULL
,	NULL
Roy	NULL
Matthew	NULL
,	NULL
D.	NULL
Fennell	NULL
Evans	NULL
,	NULL
and	NULL
Robert	NULL
P.	NULL
Hebbel	NULL
,	NULL
Departments	NULL
of	NULL
Medicine	NULL
and	NULL
Chemical	NULL
Engineering	NULL
,	NULL
University	NULL
of	NULL
Minnesota	NULL
,	NULL
Minneapolis	NULL
,	NULL
M	NULL
N	NULL
55455	NULL
.	NULL
)	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

®	NULL
blO	NULL
0d	NULL
1998	NULL
92	NULL
:	NULL
1225-1234	NULL
Bcl-3	NULL
Expression	NULL
and	NULL
Nuclear	NULL
Translocation	NULL
Are	NULL
Induced	NULL
by	NULL
Granulocyte-Macrophage	NULL
Colony-Stimulating	NULL
Factor	NULL
and	NULL
Erythropoietin	NULL
in	NULL
Proliferating	NULL
Human	NULL
Erythroid	NULL
Precursors	NULL
A	NULL
_	NULL
g	NULL
``	NULL
JO	NULL
430°	NULL
“	NULL
?	NULL
)	NULL

``	NULL
O19nN	NULL
i	NULL
{	NULL
®	NULL
Min-Ying	NULL
Zhang	NULL
,	NULL
Edward	NULL
W.	NULL
Harhaj	NULL
,	NULL
Laurie	NULL
Bell	NULL
,	NULL
Shao-Cong	NULL
Sun	NULL
and	NULL
Barbara	NULL
A.	NULL
Miller	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/92/4/1225.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Hematopoiesis	NULL
and	NULL
Stem	NULL
Cells	NULL
(	NULL
3573	NULL
articles	NULL
)	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

